HOSPITALS Magazine issue 60

Issue 60 / 180 SEPT-OCT 2021

THE ARAB HOSPITAL APPLICATION IS AVAILABLE

Patrick van der Loo

Regional President for Africa & the Middle East - Pfizer

T +44 20 7993 0030 M +971 55 7271094 info@gamahelthcare.com, a.elkhidir@gamahealthcare.com 2 www.gamahealthcare.com

Publisher Arab Health Media Communication General Manager Simon Chammas schammas@tahmag.com Creative Department Roula Haddad - Georges Habka

HOSPITALS’ HUMANITARIAN INITIATIVES

A WINDOW OF HOPE FOR A BRIGHTER FUTURE Anyone that keeps abreast of hospital activity notices successive developments and pioneering initiatives, in order to improve service, develop performance and upgrade the level of attention to patients in particular and to people in general. The repercussions of the coronavirus pandemic have contributed to activating this trend that existed before that in many hospitals. Some initiatives focused on mental health in parallel with physical health, which contributes to enhancing health security for individuals as well as for society as a whole.

As soon as the danger of coronavirus began to recede, even if relatively, hospitals directed their efforts in a more focused manner on other important aspects that help patients, even in ways and methods that previously seemed outside the framework of medicine or health promotion, and began launching educational, recreational and humanitarian initiatives that were praised by everyone.

The expansion and success of these initiatives is because they are receiving support from the hospital sector and are accepted by the public. For instance, to name a few, is Al-Ahli Hospital’s initiative in Qatar entitled “Read for your Health”. It is an initiative that invites people to educate themselves in health with the aim of raising awareness, knowing the health risks and preventing them, which helps build better health for the individual and relieves unnecessary pressure on the medical sector.

Since cooperation is key to success, “Hospitals” magazine commends and welcomes such initiatives and utilizes all its potential to help them succeed, in order to deploy their benefit, enhance the health of the individual and the safety of society, which is the ultimate goal of every action and initiative.

Publisher

Creative Director Jessy E. Hajj Photographer Hanna Nehme Copy Editor Jessica Achkar Editors Aline Debes, Mark Steven, Don Karn, Andrew Weichert, Colette Semaan, Abbas Moussa, Elham Najem Advertising & Marketing advertising@tahmag.com Mirna Khayrallah mirna@tahmag.com Business Development Manager Elie Yammine Offices & Adresses AHMC, Lebanon Mansourieh High way, Jihad Wakim center, 3rd floor.

T/F: +961 4 53 40 58 M: +961 3 60 61 00 tahmag@tahmag.com Simon Chammas schammas@tahmag.com Dubai Schammas@tahmag.com +967 50 2971007

Printing

Distribution KSA - UAE - OMAN - TURKEY LEBANON - JORDAN - KUWAIT BAHRAIN - QATAR - EGYPT All rights reserved by the HOSPITALS magazine. No part of this publication can be reproduced in any form without prior permission in writting from the publisher.

3

4

SEPT . OCT 2021

12 “Efforts to get Pfizer/BioNTech COVID-19 vaccine to every corner

of the world has reinforced my belief in Pfizer to achieve the impossible”

COVER STORY

12 Patrick van der Loo Regional President for Africa & the Middle East - Pfizer

NEWS

10 Hospital Gowns Market Size Worth US$8.29 Billion By 2028 | CAGR: 13.2% 18 A delegation from Dubai Health Authority (DHA) visits Moro Hub 24 Registration for the 9th Pan Arab Human Genetics Conference is now Open 26 The Abu Dhabi Department of Health and Abu Dhabi Residents Office launch new packages to help doctors apply for Golden Visas 30 Gargash Hospital Celebrates 2 years of Operational Excellence, Announces Aggressive Plans for 2022 32 GMG strengthens health portfolio to inspire wellbeing across the UAE 36 SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate 38 Priory expands its mental health provision in the Middle East 40 Corniche Hospital launches new ‘on demand’ patient menu and upgrades kitchen equipment

SEPT.OCT 2021

6

42 Valiant Clinic and Hospital offers luxurious touch to healing with the opening of VIP inpatient wing 44 New WCM-Q program ‘Science for Curious Minds’ inspires high school students 46 Roche Diagnostics appoints new General Manager for the Middle East

ARTICLES

34 GE Healthcare: The Road to Efficient, Quality PatientCentric Care 48 Errors in healthcare organizations occur due to system and process, why investigating individual errors…

68 VOCERA: Employing the Power of AI and Interoperability to Reduce Sepsis Mortality 74 VOCERA: Niagara Health Reduces Number of Injuries in Code White Emergencies by 20% – Staff Feel Safer While They Work 88 Al-Ahli Hospital performs complex gynaecological surgery 89 Al-Ahli Hospital performs successful lumbar fusion surgery 90 Hypertension… Did you get a high blood pressure reading? What to do next?

96 Immunotherapy

SEPT . OCT 2021

52 #Hospotel Services

#HOSPOTEL

52 #Hospotel Services 59 Acıbadem Healthcare Group 64 HOSPOTEL, The future hospital with seamless integration of wellness and hotel

FEATURES

70 Emerging Healthcare Technology 78 Laboratory Sample Tubes 80 Breast cancer treatment 82 Obesity Medicine

80 Breast Cancer

SEPT.OCT 2021

8

78 Laboratory Sample Tubes

INTERVIEWS

76 Richard Wood, MD, Chief of Colorectal and Pelvic Reconstructive Surgery at Nationwide Children’s Hospital

EXHIBITIONS

92 MEDICA 2021 + COMPAMED 2021: For the restart as an in-person event, participations reflect the optimism of the medical technology industry 94 Over 200 leading healthcare thinkers and experts lined up for the 44th World Hospital Congress

82 Obesity Medicine

HELPING DELIVER BETTER OUTCOMES. A more efficient lab can lead to faster results, which in turn can improve patient outcomes.

Across the healthcare continuum, BD combines advanced automation with fully integrated products, expertise from pre- to postanalysis, and sophisticated informatics to streamline lab workflows and accelerate turnaround times for more accurate results. This also helps measurably drive down costs across the entire lab for chemistry, microbiology, molecular and clinical flow cytometry. From discovery to the delivery of care, this is the difference of a broad portfolio of BD solutions, insights and global partnerships. Discover the diagnostic difference one company can make. Discover BD.

Learn more about BD at bd.com/en-mena/our-products bdbiosciences.com/en-eu/instruments Not all products, services or features may be available in your local area.

Please check with your local BD representative.

© 2021 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.

NEWS

Hospital Gowns Market Size Worth US$8.29 Billion By 2028 | CAGR: 13.2%

T

he global hospital gowns market size is expected to reach USD 8.29 billion by 2028 according to a new study by Polaris Market Research. The report “Hospital Gowns Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical Gowns, Non-Surgical Gowns, Patient Gowns); By Usability (Disposable, Reusable),

By Risk Type (Minimal, Low, Moderate, High), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising cases of road accidents and trauma events resulted in increased hospital admissions, which led to the higher adoption of hospital gowns to ensure the safety of caregivers in the market. For instance, according to the market statistics published by the WHO, in India alone, approximately 1 lac people suffer from severe to moderate burns, every year.

According to the market statistics of the Healthcare Cost and Utilization Project (HCUP), each year around 9,942,000 was performed in the U.S. alone. Moreover, NCBI in 2017, has reported that the rise in the incidence of burns and wounds is high in countries such as UK, Australia, Finland, China, Bulgaria, and Netherland.

Such high cases have significantly propelled the market growth of hospital gowns.

Asia Pacific market for hospital gowns is projected to register a lucrative growth rate over the assessment period. This market growth is expected due to the rapid advancements in the healthcare infrastructure, awareness regarding caregivers and patient safety, and government-sponsored investments in hygiene standards. Most of the countries in the region have contracts with the third level firms to procure their laundry requirements. Rising demand for hospital gowns in healthcare facilities and their role in limiting transmission of infectious diseases has boosted the demand for such products.

Hospital gowns industry participants such as Medline Industries, Inc., Angelica Corporation, AmeriPride Services, Inc., Standard Textile Co., Inc., 3M, and Cardinal Health are some of the key players operating in the global market.

Companies are focusing on research and development initiatives to develop technologically advanced products and to stay competitive in the market.

COMPANIES IN THE HOSPITAL GOWNS INDUSTRY ARE ENGAGED IN MERGERS AND PARTNERSHIPS TO STRENGTHEN THEIR PORTFOLIO OF OFFERINGS AND TO INVIGORATE THEIR MANUFACTURING CAPABILITIES. FOR INSTANCE, IN 2018, ARAMARK CORPORATION COMPLETED THE ACQUISITION OF AMERIPRIDE SERVICES TO STRENGTHEN AMERIPRIDE’S BUSINESS AND CUSTOMER BASE.

In line with this, in March 2020, the U.S. based company Standard Textile have boosted the production of personal protective equipment, including hospital gowns, face masks, and shields, to protect frontline healthcare workers with protection against the COVID-19 pandemic.

https://www.polarismarketresearch.com/ industry-analysis/hospital-gowns-market/ request-for-sample

SEPT.OCT 2021

10

DICOM Medical Printers

A First in Digital Printer Technology OKI’s DICOM medical printers combine the cost effectiveness and high quality output of an LED printer with embedded DICOM software. This allows you to print directly from medical equipment without the use of conversion software or external print servers. Easy-to-use, devices.

www.okime.ae/dicom

COVER STORY

Patrick van der Loo Regional President for Africa & the Middle East - Pfizer

“Efforts to get Pfizer/ BioNTech COVID-19 vaccine to every corner of the world has reinforced my belief in Pfizer to achieve the impossible”

SEPT.OCT 2021

12

COVER STORY

P

fizer is one of the world's largest research-based pharmaceutical and biomedical companies. “Hospitals” magazine had the privilege to meet with Patrick van der Loo, Regional President for Africa & the Middle East - Pfizer to talk about his journey with Pfizer, the pandemic and the challenges they faced during this time, the company’s vision, among other issues. Below is the full interview:

You joined Pfizer in 1997, and in 2020 you were appointed Regional President for Africa and the Middle East. Can you tell us more about your journey with Pfizer?

Since first joining the team in Europe and then North America back in 2006, I've been fortunate enough to gather a wealth of experience at Pfizer across multiple business divisions (from marketing to business development), regions and offices. Early on in my career, I spent a fair amount of time in our New York headquarters, which gave me a real sense of how our business operates and placed me in great stead for what was to be the next significant move of my career to Asia.

Overseeing several markets as cluster lead, including India, Pakistan, Australia, New Zealand, and Korea, I lived in Hong Kong, Japan, and Thailand. Living and experiencing these vast and diverse regions fundamentally shaped who I am personally and professionally. It was a rich and rewarding experience and allowed me to immerse myself in different cultures and learn about the dynamics of emerging markets.

Despite the many differences between all these geographies and the people who inhabit them, an underlying dynamism characterizes these emerging markets that make them exciting places to be. I feel the Middle East and Africa share this dynamism, and I thoroughly enjoy working with our patients and all our stakeholders in the market to deliver meaningful breakthroughs for patients.

The pandemic year was so challenging for all across the globe and especially to pharmaceutical companies. How did you feel to be part of a company that was one of the leaders fighting this pandemic?

Efforts to get Pfizer/BioNTech COVID-19 vaccine to every corner of the world has reinforced my belief in Pfizer to achieve the impossible. More than a year following the outbreak of this global pandemic, our vaccine development and delivery achievements have demonstrated Pfizer's remarkable ability to use its scale and heritage to deliver meaningful breakthroughs that change patients' lives.

With the COVID-19 vaccine, we decided from day one to leverage decades of experience and expertise in vaccine development, testing, manufacturing, and distribution to make a vaccine for ALL patients – no matter where they live. To date, our vaccines have reached more than 120 countries and territories in every region of the world, and we are expanding that reach every day.

In addition, to accelerate our efforts to help save even more lives across the globe, we have pledged to provide 2 billion doses of our COVID-19 vaccine to low- and middle-income countries in 2021 and 2022 – 1 billion doses each year. As part of this pledge, Pfizer and BioNTech will provide 500 million doses at the not-for-profit price - 200 million in 2021 and 300 million in 2022 - to support multilateral efforts to address the surge of infection in many parts of the world. The government will, in turn, donate the doses to the 92 COVAX Advanced Market Commitment (AMC) countries as well as the member states of the African Union that are not already part of the AMC 92.

In my role as president of the Middle East and Africa, the implementation and execution of the Pfizer/BioNTech COVID-19 vaccine is one of the first projects I oversaw regionally.

As part of this project, our team continues to collaborate with numerous governments and ministries on some of the earliest rollouts of the vaccine worldwide. Overall, working on this project has been a personal honor, knowing that our work makes a real difference in patients' lives. It has also given me some great insights into the regional healthcare industry and the breakneck speeds at which authorities deliver innovations.

It makes me highly motivated and excited to see what else will come out of our work in the region over the coming months and years ahead.

WE REMAIN FOCUSED ON WHERE AND HOW WE CAN MAKE THE MOST SIGNIFICANT IMPACT – PROVIDING NOVEL, SCALABLE AND SUSTAINABLE ACCESS SOLUTIONS; BRINGING PFIZER BREAKTHROUGHS TO ADDRESS THE MOST PRESSING GLOBAL HEALTH NEEDS; AND INVESTING IN PEOPLE, MARKETS, TECHNOLOGY, AND DATA TO STRENGTHEN HEALTHCARE SYSTEMS FOR THE MOST VULNERABLE PEOPLE.

13

COVER STORY

What were the challenges you faced during this time, and what were the lessons learned?

We have been operating here in AfME for over the past 60 years. We strive to become a reliable partner for countries fighting the pandemic in every corner of the globe and similarly across AfME. Following our experience with COVID-19, we now have learnings about regulatory processes, contracting, and rapid supply to ensure that our breakthrough medicines for some of the most urgent health threats reach even more people.

Our commitment to fighting infectious diseases doesn't stop at medicine. For example, in low- and middle-income countries, we realize that health systems continue to be a big challenge. There is an urgent need to strengthen the systems, improve the prevention, diagnosis, and treat infectious diseases, particularly for underserved and vulnerable populations. Pfizer and The Pfizer Foundation, working with partners, are investing in multi-year commitments to improve health system resiliency, including training healthcare workers, strengthening supply chains, ensuring access to quality products, and supporting new technologies that help to improve diagnosis and data collection.

The mission statement of Pfizer is to deliver breakthroughs that change patients’ lives. Where is Pfizer in accomplishing this mission and purpose today?

At Pfizer, we remain committed and steadfast in our mission to deliver breakthroughs that change patients' lives.

More than 1,600 colleagues support Pfizer across AfME today. For over 60 years, we have been working tirelessly, in partnership with healthcare professionals, communities, and governments, to change the lives of millions of people across 19 countries in AfME. We partner to increase access and affordability of Pfizer's breakthroughs in core therapeutic areas across AfME, including vaccines, medicines for oncology, inflammation and immunology, internal medicine, rare diseases, and anti-infectives and sterile injectables used both in and outside of

SEPT.OCT 2021

14

the hospital setting. We continue to be driven by science, discovering breakthroughs that change patients' lives.

In 2020, we have managed to register 55 products and reach approximately 6.6 million patients in AfME countries.

Another area in which we are making a significant impact on patient lives is vaccinations. We supply Pfizer pneumococcal conjugate vaccine to 15 countries National Immunization Programs which helps vaccinating around four million newly born babies every year.

What is Pfizer’s vision for the future, and what is the key to a healthier future in your opinion?

At Pfizer we envision a future where disease doesn't win, but science does, and that every patient, regardless of where they live, will have access to life-saving medicines, treatments, and vaccines. We focus on creative, innovative, and scalable solutions that address all unmet needs and critical public health challenges.

If COVID-19 taught us anything, it was that we could not solve healthcare challenges in silos. We must all – patients, industry bodies, governments, and industry players work together to achieve better health for all. Today, as we continue to collaborate with our partners, we focus on developing the necessary infrastructure to encourage industry-wide innovation and growth, including R&D capabilities, regulatory environments, and fostering local talent.

Together these efforts are designed to help us deliver more breakthroughs locally to meet unmet patient needs. We can only achieve this by sharing and cooperating in expertise with industry stakeholders.

How do you evaluate the region that you are responsible of? Especially that this region is known for significant challenges in healthcare.

The healthcare sector across AfME is at a critical point today, rapidly growing to meet the population's needs. Governments are making considerable investments in the industry as they seek to improve the health of their citizens and economies. There are, however, key challenges

I FEEL THE MIDDLE EAST AND AFRICA SHARE THIS DYNAMISM, AND I THOROUGHLY ENJOY WORKING WITH OUR PATIENTS AND ALL OUR STAKEHOLDERS IN THE MARKET TO DELIVER MEANINGFUL BREAKTHROUGHS FOR PATIENTS.

COVER STORY

facing the regional industry. As we seek to deliver medical breakthroughs that change lives, two of our primary challenges are 1) the regulatory environment and 2) future talent.

In recent years at Pfizer, we have undergone significant evolution from a diversified company with a comprehensive portfolio of legacy brands to a science and innovation-focused biopharmaceutical powerhouse. As we focus on delivering medical breakthroughs in the region, one of our primary objectives is to support research and development. Creating an environment where R&D can flourish requires an ecosystem underlined by robust regulations that enable and encourage investment. That includes ensuring that sufficient protections are in place for all those involved in the development process.

Intellectual Property (IP) protection, for example, is essential to guaranteeing investment into risky, costly, complex, and lengthy R&D. Without these protections, our efforts to meet unmet patient needs face serious challenges.

That brings me to the second challenge we face regionally, which is talent. Besides having the proper framework to facilitate medical breakthroughs, we need to ensure that we have the talent to drive innovation. Across AfME, we have many bright young minds ready to lead the industry, but we need to support them with our industry expertise to help them flourish.

From encouraging STEM education at an early age to women in the industry and educating students on the opportunities available to them across the biopharma industry, we are keen to support the development of the industry's future leaders.

In the case of both these challenges, we are collaborating with industry stakeholders, from government authorities to industry bodies, to advance the healthcare industry collectively for the benefit of patients. Today, for example, there is an incredible R&D project ongoing in Saudi Arabia, where multiple clinical trial protocols (phases 2 and 3) are under review.

Several have already reached the final stages of development and approval in oncology, vaccine, public health, and gene therapy in Saudi Arabia.

The trial of gene therapy in Duchenne's disease at King Faisal Specialist Hospital and Research

Centre, for example, is a crucial milestone for us regionally. These trials would not have been possible without the willingness of local research centers and authorities to work together.

As for helping to support talent, our flagship initiative in Algeria – B-Imitiyaz – thanks to the partnership between the Ministry of Education and several universities – is seeing current students learn about all the latest developments in our industry from world-leading experts.

Initiatives such as these encourage our future generation of industry leaders and are possible only through collaboration.

There are lots of unmet patient needs worldwide and particularly in Africa and the Middle East region. How are you planning to meet the region's needs, and what are the strategies you are using?

We remain focused on where and how we can make the most significant impact – providing novel, scalable and sustainable access solutions; bringing Pfizer breakthroughs to address the most pressing global health needs; and investing in people, markets, technology, and data to strengthen healthcare systems for the most vulnerable people.

To identify the gaps in the patient journey and address them, we partner with governments across AfME, global health organizations, and traditional and non-traditional players in the health space. By working closely with our local partners, we tailor our solutions to the specific

IN MY ROLE AS PRESIDENT OF THE MIDDLE EAST AND AFRICA, THE IMPLEMENTATION AND EXECUTION OF THE PFIZER/ BIONTECH COVID-19 VACCINE IS ONE OF THE FIRST PROJECTS I OVERSAW REGIONALLY.

15

COVER STORY

needs of these patients: ranging from financing solutions to ancillary services such as doorstep deliveries supported by virtual healthcare.

Pfizer has made a substantial investment in the Biovac Consortium, a private-public partnership that provides significant workforce development training to healthcare professionals in South Africa to locally produce the company’s pneumococcal conjugate vaccine. Our company has invested $24.5 million to date in this partnership of which more than 50% dedicated for the Technology Transfer. Once Pfizer’s workforce development regiment and full technology transfer have been successfully completed, more than a million babies will be treated annually with our product through the government’s expanded program on immunization. Moreover, once the South African scientists’ training is complete, the expectation is that they will collaborate with Pfizer on future endeavors to provide localized insight into the most pressing healthcare challenges in the region. As a result of this activity, South Africa would most likely become the world’s first low-resource market to develop a vaccine against Group B Streptococcus (GBS) infection.

SEPT.OCT 2021

16

One of the greatest access barriers to Pfizer’s products across Sub-Saharan Africa is the “last mile” challenge, access to affordable healthcare into the hands of patients. This has been spotlighted across the world, although there is a priority to focus on this in relation to the African continent needs. Many urban and rural communities across the continent without reliable infrastructure cannot receive biological materials. To address this challenge, Pfizer is investing in two pioneering ventures. The first is a strategic funding collaboration with Zipline, a California-based company that assembles specialty drones in the United States and operates them in Africa to deliver our products. To-date, Zipline has made over 20,000 deliveries, impacting almost 11 million people in Rwanda and Ghana. The second project is with U.S.-based Not Impossible Labs, which is creating driverless, solar-powered boats to deliver products across remote Sub-Saharan Africa.

Trachoma is the world’s leading cause of infectious blindness. To heed the World Health Organization’s call to eliminate blinding trachoma, Pfizer has partnered with the International Trachoma Initiative (ITI) to reduce the disease in-

AT PFIZER, WE WORKED TIRELESSLY TO RESPOND TO PATIENTS' MOST SIGNIFICANT MEDICAL NEEDS IN A TIME OF CRISIS AND DID WHAT MANY THOUGHT IMPOSSIBLE. WHAT USUALLY TAKES YEARS IN TERMS OF DEVELOPMENT WE ACHIEVED IN RECORD TIME WITH OUR PFIZER/ BIONTECH COVID-19 EFFORTS.

COVER STORY

cidence across Africa. 27 Sub Saharan countries are included in this program and to date, Ethiopia which has the highest burden of trachoma as of 4th of January 2021 has received 455.7 million treatments of the Azithromycin donation which is 49.7% of the Global donation while Ghana had reached trachoma elimination by 2018. More recently in April 2021, Gambia was validated by the WHO for eliminating trachoma as a public health problem. Pfizer’s current commitment is to support the program till 2025.

How do you see the world today after the pandemic? Do you think we are now ready to face similar or maybe more dangerous pandemics in the future?

A global pandemic is a healthcare crisis, and, in many ways, we are never 100% fully prepared for a crisis of this scale and nature.

Nonetheless, we have learned a tremendous amount from the events of the last year to year and a half and demonstrated the industry's resilience in overcoming challenges.

At Pfizer, we worked tirelessly to respond to patients' most significant medical needs in a time of crisis and did what many thought impossible.

What usually takes years in terms of development we achieved in record time with our Pfizer/ BioNTech COVID-19 efforts. We also demonstrated our ability to work with our industry peers for the benefit of patients worldwide.

While the pandemic is still not behind us, our efforts are focused on continuing to roll out and ensure access to the vaccine for patients everywhere. What we have learned from these events, however, is that we must work together to solve healthcare crises – it is impossible to solve them otherwise. As for crisis preparedness, it is down to our work together with authorities to ensure that, faced with another pandemic, we have everything in place, from R&D to global supply chains, to ensure we are ready to deal with any future healthcare challenges. At the same time, we will continue to leverage technology to overcome patients' challenges in accessing quality healthcare and life-saving medications. New technologies and service models are increasingly being used to deliver vital healthcare to the world's most vulnerable communities.

What do you think is the role of communities and governments in the improvement of the lives of people and in protecting them from future health threats?

From patient communities to government authorities and industry bodies, each of us has a part to play in ensuring we have resilient healthcare systems that meet patients' needs.

Pfizer continues to work across AfME to drive pro-patient innovation, policies, and reforms to strengthen health systems with the support of governments, NGOs, private sector partners, and industry associations.

Public-private partnerships are critical to our work at Pfizer, enabling many of our most exciting initiatives.

Pfizer AfME joined hands with Wellcome to launch the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR), a new multi-year, public-private research collaboration with the governments of Ghana, Kenya, Malawi, and Uganda to track resistance patterns and better understand the burden of AMR on patients living in low- and middle-income countries.

What are you doing to drive greater access and provide affordable solutions across AfME? Our Patient Access Programs help eligible patients who cannot afford the treatment cost of the Pfizer medicines prescribed by their physicians. With more than 30 programs in 11 countries across Africa and the Middle East, we provide affordability solutions and support the lives of over 4.500 patients suffering from various oncology, inflammatory and rare diseases.

Moreover, we are working in several countries on Managed Entry Agreements with particular focus on health outcome-based models in order to accelerate access to innovation.

In addition, we are working with PHRMAG in the region to support the efforts of the governments to develop policies aimed at creating headroom for innovative medicines by achieving greater efficiencies in spending on off-patent medicines and other health system policies related to pharmaceutical spending.

TRACHOMA IS THE WORLD’S LEADING CAUSE OF INFECTIOUS BLINDNESS. TO HEED THE WORLD HEALTH ORGANIZATION’S CALL TO ELIMINATE BLINDING TRACHOMA, PFIZER HAS PARTNERED WITH THE INTERNATIONAL TRACHOMA INITIATIVE (ITI) TO REDUCE THE DISEASE INCIDENCE ACROSS AFRICA.

17

NEWS

A delegation from Dubai Health Authority (DHA) visits Moro Hub

H

E Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA) welcomed a high-profile delegation from Dubai Health Authority (DHA), spearheaded by HE Awad Al Ketbi, Director General of DHA at Moro Hub (Data Hub Integrated Solutions LLC), a subsidiary of Digital DEWA, the digital arm of DEWA. The visit aimed to offer deep insights into Moro Hub’s advanced technologies, as well as enhance cooperation between the two parties.

The visit was attended from MORO Hub side

by Eng. Marwan Bin Haidar, VC & Group CEO of Digital DEWA, Matar Al Mehairi, Board Member of Digital DEWA, Mohammad Bin Sulaiman, CEO of Moro Hub; along with Chief Information Security Officer of DEWA and Moro Hub, Dr. Ahmed Al Ketbi. The high-profile delegation from Dubai Health Authority comprised of Dr. Alawi Alsheikh, Deputy Director General, Saleh Al Hashimi, CEO Dubai Health Insurance Corporation, and Ahmed Al Nuaimi, CEO of Joint Corporate Support Services.

“Moro Hub works as per the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai to position the UAE as a leader in digital solutions. As such, our services are designed and developed to help government and private organisations in their digital transformation journeys. Backed by artificial intelligence (AI), cloud and the internet of things (IoT),

SEPT.OCT 2021

18

among others, Moro Hub’s next-generation digital services are focused on customer success and play an integral role in the digital transformation journey of the UAE and the Middle East,” said HE Saeed Mohammed Al Tayer.

“Dubai has established its leading position in anticipating the future. It is at the forefront of cities that anticipate and shape the future through government plans and strategies. These include the UAE Centennial 2071 that aims to make the UAE the world’s leading nation. Moro Hub’s services are in alignment with Dubai’s 10X initiative, which aims to position the emirate 10 years ahead of other cities worldwide. We are confident that these services will have an instrumental focus in DHA’s digital journey, as well as position Dubai as the smartest city in the world,” added HE Saeed Mohammed Al Tayer.

HE Awad Al Ketbi applauded Moro Hub for its endeavours to bring a positive digital transformation in the UAE. He said, “Moro Hub has been at the forefront of organisations that are exerting relentless efforts to contribute to the digital journey of the UAE. The company and its data centres have achieved a series of significant achievements in the digital arena through offering a series of world-class services.

We underscore the value and importance of the collaboration between DHA and Moro Hub in the coming period to further strengthen the efforts of the Authority and its goals to reach a better health future.”

DURING THE VISIT, THE DELEGATION TOURED IN MORO HUB’S WORLDCLASS DATA HUB AND ITS STATEOF-THE-ART SMART CITIES COMMAND AND CONTROL CENTRE; FOCUSING ON THE OPERATIONS OF MANAGED SERVICES OPERATIONS CENTRE, IOT OPERATIONS CENTRE AND CYBER DEFENCE CENTRE. ADDITIONALLY, THE EXECUTIVE TEAM OF MORO HUB INTRODUCED DHA TO A SHORT PRESENTATION ON THE ENHANCED SERVICES OFFERED

BY MORO HUB.

NEWS

NEWS

Bayer’s Eliapixant significantly decreased cough frequency in Phase IIb trial in patients with refractory chronic cough

B

ayer announced the results from PAGANINI, the Phase IIb dose-finding study evaluating the efficacy and safety of its investigational orally administered, potent and selective P2X3 receptor antagonist eliapixant (BAY1817080) in patients with refractory chronic cough (RCC).

The primary efficacy outcome was met showing a statistically significant reduction in the 24-hour cough count (average hourly cough frequency based on 24-hour sound recordings) of up to 27% for eliapixant 75 mg twice daily over placebo after 12 weeks of treatment. In the study, eliapixant demonstrated a positive benefit-risk profile, with the vast majority of adverse events considered mild or moderate. Discontinuation of the study due to adverse events occurred in 8% of patients treated with eliapixant.

Taste-related adverse events were reported in 24% of patients treated with the highest dose of eliapixant 150 mg twice daily and markedly less in patients receiving lower doses. Most were described as “a little” and “somewhat” bothersome, none described as “extremely” bothersome. The favourable tolerability of eliapixant in this trial is consistent with earlier clinical findings.

As a result, eliapixant may have the potential for safe and effective long-term use. RCC affects one to five percent of people worldwide and often has a debilitating effect on the quality of patients’ lives. Currently, no treatment is approved for the therapy of RCC, and the medical need for new effective treatments is high.

“Given the high unmet medical need, we are very encouraged with the positive outcome of eliapixant in the chronic cough indication regarding efficacy and safety,” said Christian Rommel, Member of the Executive Committee of Bayer AG's Pharmaceutical Division and Head of Research and Development. “The selective mechanism of action of eliapixant appears to be translating into improved tolerability in clinical trials. These results will guide us to advance our clinical development strategy of eliapixant.”

“Chronic cough is a common clinical condi-

SEPT.OCT 2021

20

tion with significant impact on quality of life and for which effective therapy remains an unmet clinical need. Over the past decade, there has been a major shift in how we approach this problem, driven by better appreciation of the clinical manifestation of chronic cough and an improved understanding of the associated neurobiology,” said Dr. Lorcan McGarvey, Professor of Respiratory Medicine, Wellcome-Wolfson Institute of Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast. “The findings from the PAGANINI trial with eliapixant are very encouraging, showing a promising outcome to address this unmet need. Such advancements are needed to offer new treatment options to patients with refractory chronic cough who are often suffering for many years without a relief.”

The results of the eliapixant PAGANINI study were presented at the virtual European Respiratory Society (ERS) International Congress 2021 (Abstract #BA23231).

Significant improvement in 24hour cough counts over placebo after 12 weeks of treatment and with a favorable safety and tolerability profile / Results from PAGANINI Phase IIb dose-finding study presented at the virtual European Respiratory Society (ERS) International Congress 2021 / Currently no treatment approved for refractory chronic cough, a condition affecting one to five percent of people wordwide.

About the Phase IIb Study The Phase IIb study (PAGANINI, NCT04562155) is an international placebo controlled, randomized, double-blind, parallel group, dose-finding study to evaluate the efficacy, safety and tolerability of eliapixant compared to placebo in patients with RCC. In this study, 310 participants received either 25, 75 or 150 mg of eliapixant or placebo tablets twice daily for 12 weeks. Observation for each participant lasted about 18 weeks in total. Participants were asked to wear a digital device to record the cough and to complete questionnaires to document the symptoms subjectively.

Blood samples were collected to monitor safety and measure the blood level of the study drug.

About Eliapixant Eliapixant (BAY1817080) is an investigational orally administered, potent and selective P2X3 receptor antagonist. The P2X3 receptor is a key modulator of afferent nerve fiber signaling, thus considered to play a central role in diseases with nerve hypersensitization such as cough hypersensitivity syndrome. P2X3 receptor antagonists block the receptor aiming to decrease peripheral nerve fiber sensitivity. In addition to RCC, eliapixant is currently being evaluated in Phase II clinical trials for the treatment of endometriosis, overactive bladder and neuropathic pain. The P2X3 receptor antagonist was derived from Bayer’s former strategic alliance with Evotec SE, a global drug discovery and development company.

NEWS

Sheikh Shakhbout Medical City successfully completes complex knee replacement surgery using hand-held accelorometer technology

T

he orthopaedic surgery team at Abu Dhabi-based Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a joint-venture partnership between Mayo Clinic and Abu Dhabi Health Services Company (SEHA), has successfully completed knee replacement surgery on a 85-year-old, female patient with a complex case using minimally invasive computer-guided technology. The technology was used for the first time in Abu Dhabi.

The surgery was conducted using a handheld computer navigation system. This is an accelerometer navigation system that aids in hip and knee replacement surgeries, making them more streamlined and time efficient.

Dr Feras Ya’ish, Orthorpedic Surgeon at SSMC said: “Our patient had difficulty walking due to the heavy pain in both her left and right knees, and she also had severe arthritis in her right knee. The patient has existing metalwork inserted into her thigh bone which was from a years-old fracture that would have made the knee replacement procedure difficult. She did require the surgery to restore her mobility, but her case was considerably complex, which is why she was referred to SSMC.”

A secondary challenge was that the patient is of an advanced age with preexisting comorbidities including ischemic heart disease, lung disease, and renal failure. To ensure maximum benefit from the knee replacement, the patient’s knee was initially injected for temporary pain relief for a few weeks, which also helped restore a certain degree of mobility. Once the pain improved, the patient’s walking improved, which was a key indication that performing the knee replacement surgery would be effective in improving her overall mobility.

Another element the surgeons needed to consider was the existing presence of metalwork in the patient. The usual process of a knee replacement surgery requires the placement

SEPT.OCT 2021

22

Dr Feras Ya’ish

SENIOR PATIENT WITH PRE-EXISTING COMORBIDITIES SUCCESSFULLY UNDERGOES COMPLEX KNEE REPLACEMENT SURGERY USING HAND-HELD ORTHOPAEDIC TECHNOLOGY FOR THE FIRST TIME IN ABU DHABI, REDUCING SURGICAL TIME AND ENHANCING RECOVERY.

of metalwork to be used as a guide inside the canal of the bone. In this patient’s case, this couldn’t be done due to the existing metalwork.

Removing the first set of metalwork would have presented a significant risk of the bone breaking where the metal was situated, as the patient is osteoporotic and this would have also required that the patient undergo a second surgery, which, given her age and preexisting conditions, was not recommended.

“The best option for her was to do the knee replacement while keeping the existing metal.

This was the catalyst for us exploring the handheld accelerometer device, as it doesn’t require penetration of the bone, which is much safer for patients, especially those who are older. It also gives accurate bone cuts and bone alignment, which is research-proven. Applying the device typically takes about four minutes, and we applied it on the knee itself, moving it as the technology learnt the orientation of the bone to give us the alignment where the bone needed to be cut, without breaching or penetrating the bone itself. From cutting to dressing, the surgery took one hour and ten minutes, and was a success. The patient was able to stand the very next day and was walking by the following day,” continued Dr Ya’ish.

The patient was in the care of a multidisciplinary team at SSMC and is now walking independently with the support of a walking aid.

The hand-held accelerometer technology is available at SSMC and will continue to be utilized for complex cases in similar patients.

Award-winning care meets humankindness.

Medical breakthroughs have continued to help people live healthier lives, and we’re honored to be recognized for them.

With our new rankings by U.S. News & World Report, we celebrate these advancements and the power of humankindness to provide healing for our communities in the best way.

Learn more at stlukeshealth.org./bslmcinternational

NEWS

Registration for the 9th Pan Arab Human Genetics Conference is now Open

Dr. Mahmoud Taleb Al-Ali

HE Abduallah bin Souqat

T

he Centre for Arab Genomic Studies (CAGS), a division of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, has announced the opening of registrations for the 9th Pan Arab Human Genetics Conference (PAHGC). The conference will be held virtually from 8th to 9th December, 2021

Talking about the scientific content of the conference, Dr. Mahmoud Taleb Al-Ali, the Director of CAGS and the Chairperson of the Scientific Committee of the conference, said, “The theme of the conference in its 9th edition is Challenges and Opportunities for Genomics in the Arab World, and the main topics to be discussed in the conference include big data genomics in Arabs, new insights into rare disease, genomics and society, and the genomics of infection and immunity. We have selected as speakers, a group of leading researchers and scientists from all over the world specializing in each of these areas, such as Dr. Khaled Fakhro and Prof.

Dr. Evan Eichler from the University of Washington. “For the first time since the inception of the conference series, we are hosting a completely virtual and free-to-register conference. Not only does this allow us to conduct a totally safe event, it will also enable delegates from outside the UAE to take part in the meeting without

SEPT.OCT 2021

24

THE CONFERENCE WILL ALSO PROVIDE A PLATFORM TO DISCUSS CHALLENGES FACED BY DEVELOPING ARAB COUNTRIES, WHICH COULD GREATLY BENEFIT FROM COLLABORATIONS WITH AND SUPPORT FROM COUNTRIES SUCH AS THE UAE AND KSA, WHICH HAVE ESTABLISHED THEIR OWN GENOME PROJECTS.

any hindrance. Networking and communication between delegates has always been our priority, and we have tried our best to ensure that the quality of networking stays the same as in a physical conference”, he added HE Abduallah bin Souqat, the Executive Director of the Award, praised the success of the previous versions of the conference, adding “The conference is a platform for specialists in the field of human genetics from all over the world to review and exchange findings and advances in this field, and it enables constructive collaborations between scientists, which helps to advance scientific research in the world in general and the Arab world in particular.”

His Excellency also extended his sincere thanks to the Dubai Health Authority, the Emirates Medical Association, and the Ministry of Health for their support of the conference.

It is worth mentioning that the theme of the conference focuses on opportunities and challenges for genomics in the Arab World, where the conference will showcase the milestones and advances in this field achieved by pioneering countries like the UAE, which has adopted an innovative health strategy highly focused on genomics and artificial intelligence.

Further details about the conference as well as registration to the event is available at www.pahgc.com

NEWS

The Abu Dhabi Department of Health and Abu Dhabi Residents Office launch new packages to help doctors apply for Golden Visas

T

he Abu Dhabi Department of Health (DoH) and the Abu Dhabi Residents Office (ADRO) have launched new packages to support and empower doctors, enabling them to apply for the Golden Visa in Abu Dhabi with added ease and peace of mind.

With the new process, doctors nominated

by DoH will be offered a VIP package to obtain their Golden Visas through the YAS Tas-heel Centre for healthcare professionals, a centre dedicated to processing Golden Visas. This VIP package will cost AED 4,000 per applicant; with this fee covering additional services such as Emirates ID, passport pickup and drop-off, and visa hold services for dependents. This cost is also inclusive of fees for application, change of status, visa stamping and Tas-heel processing.

Two non-VIP packages are also available, with the first option priced at AED 3,470 if paid through wire transfer, and the second — via online payment — at AED 3,547. These costs, however — for all packages — exclude existing visa cancellation and medical assessment fees. It should also be noted that similar fees apply for individual family members at the time of their Golden Visa applications. The non-VIP packages can also be applied through the Federal Authority for Identity & Citizenship (ICA) at: ica.gov.ae.

In addition to offering doctors more convenience, this new, streamlined process has been outlined to boost efficiency and effectiveness; eliminating the need for service centres to reach out to nominees, while allowing them to focus on serving applicants with an express interest in obtaining a Golden Visa.

Dr. Rashed Al Suwaidi, Executive Director of Healthcare Workforce Planning at the Abu Dhabi Department of Health, said: “We are working closely with the Abu Dhabi’s Residents Office to further empower doctors by ensuring their wellbeing and stability in the emirate.

The launch of these new packages speaks to our joint commitment to ensuring excellence in healthcare for the community according to

SEPT.OCT 2021

26

the global best practices. As always, the safety and wellbeing of the people and communities of the emirate remain our number one priority.

Through this collaboration, we look forward to further advancing our health sector, by attracting more doctors to Abu Dhabi, inspiring them to make the emirate their home and providing these dedicated professionals with the support they need to further contribute to the sector, ensuring the safety, happiness and wellbeing of our community.”

Sameh Al Qubaisi, Executive Director - Executive Affairs Office at ADDED said: “Committed to providing services and programmes that strengthen Abu Dhabi’s position as a preferred destination to live, work and thrive, we are pleased to have come to this understanding with the Abu Dhabi Department of Health (DoH) in organising an effective process that aims to enable doctors to lead a solid and successful career in the emirate.” “We aim to collaborate with more partners in providing world-class services that enable global talent in acquiring the Golden Visa.

Working with our valued partners at DoH allows us to do that and more, establishing a system that maximises our time, resources and efforts.

Through this aligned and collaborative approach, we hope to help as many people as we can, and encourage all nominated doctors to take full advantage of this opportunity,” he added.

THE UAE’S GOLDEN VISA IS AVAILABLE IN ABU DHABI FOR INTERNATIONAL INVESTORS AND TALENT FROM AROUND THE WORLD, PROVIDING SUCCESSFUL APPLICANTS WITH VISAS FOR UP TO 10 YEARS. GOLDEN VISA HOLDERS CAN LIVE, WORK AND STUDY IN ABU DHABI WITHOUT THE NEED OF A NATIONAL SPONSOR.

When teams provide care for COVID-19 patients, HAI reduction and efficient workflow are crucial.

The Vocera® Platform safely streamlines real-time communication for frontline providers and staff by operating hands-free, under PPE. Trusted by health systems worldwide, Vocera’s intelligent communication solution provides proven value for pandemic response and beyond.

For more information, call 800-0182438 or visit vocera.com/covid

NEWS

Gargash Hospital Celebrates 2 years of Operational Excellence, Announces Aggressive Plans for 2022

G

argash Hospital, the UAE’s first female Emirati-owned, multi-specialty hospital with primary focus on women and childcare, marked its two years of successful business on August 19th, 2021. The fast-growing healthcare facility announced exciting plans for 2022 at a grand ceremony. The eventful anniversary celebration witnessed the presence of members of Royal Family from the UAE, Dr. Husnia Gargash (Founder & Shareholder), Ghada Sawalmah (CEO) and other senior members of the Board and the management team.

“We are proud to have served the UAE community with high-quality healthcare during the past 2 years of our operations. Our directors, doctors and staff members are all very grateful for the trust that the community members have shown in us and for embracing us. We have grown in response to the needs of the community,” said Dr. Husnia Gargash, Founder and Shareholder at Gargash Hospital.

ment each other. In 2021, Gargash Hospital has added few specialities and invested in state-of-the-art technology to accommodate the demands of its growing patient base. This trend will be continued in 2022 in line with our strategic expansion plans.

“We opened our doors officially in 2019 around this time and since then it has been a steep learning curve. The sudden arrival of the pandemic created different needs and we changed our patient-flow management accordingly. In the past one year, we have seen steady growth. We will look for further expansion and look forward to our continued growth in the region,” said Ghada Sawalmah, CEO – Gargash Hospital.

Speaking about expansion plans, Ghada Sawalmah, CEO of Gargash Hospital said, “I envision us delving deeper into the subspecialities, along the line of departments that we already have. We want to outshine at all the subspecialities. Plans for developing centres of excellence in various specialties, especially Assisted Reproductive Technology and collaboration with niche providers is also in the pipeline.”

Ms. Ghada said new technologies and research continues to reinforce the significance of healthcare, and the service excellence offered at Gargash serves as an essential component of delivering good health to our customers.

As such, the hospital is investing aggressively in 2022, as part of its next phase of significant development. Under this plan, Gargash Hospital is upgrading its facility and expanding its range of services with addition of new specialities and technologies. The focus is on providing expert healthcare advice and facilities that comple-

Applauding the success, Ole Per Maloy, Managing Director Middle East and Southern & Eastern Africa Siemens Healthineers commented, “We are delighted to join Gargash Hospital in celebrating their commitment to the future of healthcare in the UAE. As a technology partner, we aim to deliver sustainable and innovative solutions to our partners enabling them to deliver best-in-class care, especially during these challenging times. We look forward to continuing our support in collectively making a positive impact for many more years to come.”

SEPT.OCT 2021

30

Gargash Hospital, a reflection of its founder’s vision of providing end-toend solutions for all gynaecological and reproductive problems, boasts a female staff of around 67 percent, with 80 percent of the hospital’s upper management comprising of women.

It was launched just before the start of the pandemic, a time when most businesses were fearing closure.

However, banking on its wide-ranging medical experience and excellence in the fields of IVF, Gynaecology, Obstetrics and General Health, the hospital has efficiently offered its patients the best of treatment and successfully survived and thrived in the unprecedented first year of business.

WELCOME TO MALAFFI CONNECTING HEALTHCARE

Malaffi, the Abu Dhabi Health Information Exchange, will connect all public and private healthcare providers in the Emirate of Abu Dhabi, to create a unified patient file and to improve healthcare quality and patient outcomes.

www.malaffi.ae /Malaffi

NEWS

GMG strengthens health portfolio to inspire wellbeing across the UAE Company to expand its retail footprint in health vertical by more than 40% in the UAE by the end of 2022

L

eading family-owned holding company GMG has confirmed plans to further expand its health-related business as the industry undergoes an unprecedented transformation.

The conglomerate’s health vertical is on track to expand its retail footprint in the UAE by more than 40% by the end of 2022.

Against the backdrop of the COVID-19 pandemic, the health industry has experienced a paradigm shift from curative to preventative care, with more consumers actively changing their approach to fitness and wellbeing.

According to a recent industry report, healthcare expenditure across the GCC will touch $89 billion by 2022.

Another global survey recently revealed changing consumer habits, with 62% of individuals saying that they have made significant lifestyle changes towards improving their health. Approximately one in three say they’re eating healthier food, while 28% say they have increased their exercise frequency during the pandemic.

GMG’s health business is in turn gearing up for a surge in consumer demand for quality health and wellbeing products and services. The company’s health portfolio currently includes prominent homegrown concepts like Supercare Pharmacy, Good Health, and Arabella Pharmacy.

Supercare is a leading healthcare, lifestyle, and pharma care company with a legacy of over 40 years. Good Health is a more recent pioneer in herbal remedies and dietary supplements, while Arabella Pharmacy provides natural, organic health products.

Mohammad A. Baker, Deputy Chairman and CEO of GMG, said: “The healthcare industry in the UAE and the wider Middle East region is transforming at a rapid pace, with consumer behavior shifting towards preventative care.

Through our diversified portfolio of health concepts, GMG is ensuring that we take proactive steps to fulfill growing consumer needs while

SEPT.OCT 2021

32

inspiring good health and wellbeing. With our expansion, we are continuing to contribute to the development of the UAE society, in line with its national ambition of building a world-class healthcare industry.”

GMG’s first foray into the health and pharma industry was in 1980 when it launched the Al Khayyam Pharmacy to improve access to medicine in Dubai, UAE. A decade later, Al Khayyam Pharmacy was rebranded to Supercare Pharmacy, and its reach gradually expanded across the UAE. The conglomerate introduced its homegrown concept Good Health in 1992, and relaunched Arabella Pharmacy this year.

Over the last several years, GMG has been expanding its global operations with a diversified portfolio of brands that now covers industries such as sports, food, and health. Operating across the GCC region and internationally, GMG has introduced more than 90 brands into the Middle East while also creating reliable and quality-driven homegrown brands.

SUPERCARE IS A LEADING HEALTHCARE, LIFESTYLE, AND PHARMA CARE COMPANY WITH A LEGACY OF OVER 40 YEARS. GOOD HEALTH IS A MORE RECENT PIONEER IN HERBAL REMEDIES AND DIETARY SUPPLEMENTS, WHILE ARABELLA PHARMACY PROVIDES NATURAL, ORGANIC HEALTH PRODUCTS.

Almoosa Heart and Lung Center - 24 / 7 Readiness

- Multiple Diagnostic and Therapeutic Options for Heart Diseases

- Exceptional capabilities in diagnosing, treating, and following up

- Best treatment methods to reach the best results and minimize the recovery period.

- Minimal Surgical Intervention using the latest technological methods

013 / 5369666 : ‫ ت‬- ‫ اﻟﻤﻤﻠﻜﺔ اﻟﻌﺮﺑﻴﺔ اﻟﺴﻌﻮدﻳﺔ‬- 31982 ‫ اﻟﺮﻣﺰ اﻟﺒﺮﻳﺪي‬- 5098 ‫ب‬.‫ ص‬- ‫ ﺷﺎرع اﻟﻈﻬﺮان‬- ‫اﻷﺣﺴﺎء‬

Al-Ahsa, Dhahran Street, P.O.Box 5098, ZipCode 31982, Saudi Arabia, Tel.: 013 5369666 www.almoosahospital.org - info@almoosahospital.com

ARTICLES

The Road to Efficient, Quality Patient-Centric Care

T

he COVID-19 pandemic has changed many things, including the perception of healthcare among business executives. Prior to the pandemic, GE’s biennial survey on global innovation found that IT, high-tech and the internet were seen as the most innovative sectors. But in the wake of the pandemic and given the response by government ministries, private healthcare providers and others, the healthcare industry came out as the top innovator in the 2020 edition of GE’s Global Innovation Barometer.

That’s no surprise for Naël Dabbagh, General Manager for the Middle East, North East Africa, Turkey and Central Asia at GE Healthcare. Long before the pandemic struck, his vocabulary was full of terms like big data, predictive analytics, and automated, cross-network data-sharing.

That’s because pre-pandemic, the healthcare industry was already beginning to explore the world of precision health, an approach that helps clinicians and healthcare systems deliver a highly personalized approach to both patient wellness and treatment of illness. That makes it possible not only to deliver higher-quality patient-centric care, but to do so in a more efficient, timely and cost-effective manner.

Precision health combines big data analysis of millions of anonymized patient medical records with each specific patient’s genetic makeup, health history, family medical history and lifestyle choices to deliver the diagnostics, treatment and monitoring required to deliver precisely the right care at the right time to each patient.

“Covid-19 really accelerated the adoption of predictive and preventative healthcare technology,” he explains. “What would have previously taken the industry years to implement is now taking months.”

SEPT.OCT 2021

34

Data delivers health The recent launch of Edison Health Services offers a good example. This platform provides an open, extendable, modern architecture for the development and deployment of AI-based digital applications in healthcare. All types of clinical, operational, and financial applications can easily be developed using these tools and securely accessed and hosted, whether in the cloud, on premises (e.g. via GE Healthcare’s Edison HealthLink appliance), or directly onto smart imaging devices like x-rays, CTs and ultrasound machines.

The potential scope for enhanced patient outcomes and operational improvements are huge, Dabbagh explains, given that the volume of medical data being generated is exploding.

TO BEGIN UNLOCKING THE POTENTIAL OF PRECISION CARE, DABBAGH SAYS, NEW AI-BASED TOOLS ARE NEEDED TO AGGREGATE, STANDARDIZE, AND QUICKLY MAKE SENSE OF THIS INFORMATION.

ARTICLES The average hospital is creating 50 petabytes of data each year, coming from a vast array of sources: devices, medical images, electronic medical records, operational and financial metrics and more. And yet, less than 3% of the data generated is actionable, tagged or analyzed.

To begin unlocking the potential of precision care, Dabbagh says, new AI-based tools are needed to aggregate, standardize, and quickly make sense of this information.

“The data in health systems and in the social domain, exists in disparate forms, in different locations and across different systems, leading to siloed and fragmented information,” he explains.

“This makes it challenging to contextualize each individual patient’s information, as well as the horizontal knowledge base within health systems acquired over decades of work, and bring it to bear at the point of care. They try to cobble together these systems, but healthcare partners want to be able to leverage data, software and analytics across their entire business, bringing together a connected, digital enterprise.”

This is an area where the power of Edison™ Health Services can help, in part by providing developers and innovation partners a platform that Dabbagh says will speed the development and adoption of AI technology in the health arena.

of distinguished clinicians, radiologists, scientists from different disciplines, senior data scientists and software developers under the newly established company CUREA, at TECHNOPOL Istanbul. Using GE Healthcare’s Edison Health Services, the teams will work to develop AI-based applications focused on the detection, categorization and severity grading of COVID-19 to diagnose and treat patients. They also will develop AI-based applications for the automatic detection and classification of breast lesions through contrast-enhanced spectral mammography (CESM).

“Over the next few years, we expect Edison™ Health Services to become central to the healthcare ecosystem and an important hub for innovation with thousands of applications and healthcare services available,” Dabbagh adds.

Security ensures privacy Dabbagh says one of the biggest requirements to fully unlocking the possibilities of precision health is ensuring robust and reliable security and privacy across all databases and other elements of the seamless system.

Partnerships produce innovation The recently launched EMEA Edison™ Accelerator, a start-up and healthcare provider collaboration program in Europe, the Middle East and Africa, is showing how this digital health platform can help. It brings together healthcare providers interested in being at the forefront of innovation, and start-ups who want to take their solutions forward by leveraging the GE Healthcare environment and GE mentoring.

Another regional collaboration around this digital platform is between GE Healthcare and Prof. Hakki Muammer Karakas, M.D., Istanbul Provincial Health Directorate Radiology Services Coordinator and Health Sciences University Faculty Member. The cooperation is the first in Turkey to accelerate AI development in medical imaging. Prof. Dr Karakas will lead the research and development teams comprised

THE RECENTLY LAUNCHED EMEA EDISON™ ACCELERATOR, A START-UP AND HEALTHCARE PROVIDER COLLABORATION PROGRAM IN EUROPE, THE MIDDLE EAST AND AFRICA, IS SHOWING HOW THIS DIGITAL HEALTH PLATFORM CAN HELP. IT BRINGS TOGETHER HEALTHCARE PROVIDERS INTERESTED IN BEING AT THE FOREFRONT OF INNOVATION, AND START-UPS WHO WANT TO TAKE THEIR SOLUTIONS FORWARD BY LEVERAGING THE GE HEALTHCARE ENVIRONMENT AND GE MENTORING.

“That’s why we’ve embedded security into the design of our devices and software systems,” he observes, “and were one of the first healthcare technology companies to create a set of ethics around how it will and won’t use AI in healthcare.”

Looking to the future, it’s clear that with comprehensive cybersecurity and a thoughtful regulatory framework in place, healthcare practitioners will continue to expand the possibilities of precision health.

For Dabbagh, precision health is still in its “infancy.” However, he’s excited by this moment: “while there is no shortage of projections on what a healthier world looks like thanks to more precise, predictive, prescriptive, efficient, and preventative care, we are already making tangible progress toward enabling that vision,” he says.

35

NEWS

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

S

K bioscience (SK) and GlaxoSmithKline plc (GSK) announced the initiation of a Phase 3 clinical study of SK’s COVID-19 vaccine candidate, GBP510, in combination with GSK’s pandemic adjuvant following positive interim Phase 1/2 results.

The randomised, active-controlled global trial will enrol around 4,000 participants from a range of countries and will aim to evaluate GBP510’s safety and immunogenicity compared to an active comparator - the AstraZeneca/Oxford University COVID-19 vaccine. The study will be one of the first global Phase 3 trials to compare two different COVID-19 vaccine candidates.

Jaeyong Ahn, CEO, SK bioscience said, "We are grateful that we were able to advance to the Phase 3 study with the unprecedented support of global initiatives, including GSK, Coalition for Epidemic Preparedness Initiative (CEPI), and the Bill & Melinda Gates Foundation (BMGF). Taking this important step towards overcoming the global pandemic situation, SK and GSK will bring our technical expertise together for the development of an adjuvanted protein-based vaccine candidate, GBP510.”

Thomas Breuer, Chief Global Health Officer, GSK said, “While many countries have made good progress with vaccination, there remains a need for accessible and affordable COVID-19 vaccines to ensure equitable access and to protect people across the world. We are pleased to contribute with GSK’s pandemic adjuvant and to be working with SK to deliver the vaccine at scale via COVAX if it is approved.”

The advance to Phase 3 study follows positive interim Phase 1/2 data which showed that all participants who received the adjuvanted vaccine candidate developed strong neutralizing antibody responses, demonstrating a 100% seroconversion rate. Neutralizing antibody titres were between five and a maximum of eight times higher compared to sera from people recovered from

SEPT.OCT 2021

36

COVID-19. No safety concerns have been identified to date in this ongoing study.

GBP510 is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein, combined with GSK’s pandemic adjuvant. The antigen is being developed by SK in collaboration with the Institute for Protein Design (IPD) at the University of Washington with support from BMGF and CEPI as part of the ‘Wave 2’ vaccine investment project to develop more accessible and affordable COVID-19 vaccines.

Results from the Phase 3 study are expected in the first half of 2022 after which, subject to positive results and regulatory approval, the vaccine is expected to be supplied at scale worldwide through the COVAX facility.

GSK commitment to tackling COVID-19 GSK’s response to COVID-19 has been one of the broadest in the industry, with two potential treatments in addition to our vaccine candidates in development. GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our pandemic adjuvant.

As well as working with SK, we are collaborating with Sanofi and Medicago to develop adjuvanted, protein-based vaccine candidates, and all are now in Phase 3 clinical trials. The use of an adjuvant can be of particular importance in a pandemic since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and contributing to protecting more people in need.

GSK is also exploring potential therapeutic or treatment options for COVID-19 patients.

We are collaborating with Vir Biotechnology to develop existing and identify new anti-viral antibodies that could be used as therapeutic or preventive options for COVID-19. Sotrovimab, a monoclonal antibody for the early treatment of COVID-19 in adults at high risk of hospitalisation, received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) in May 2021. We are also assessing whether an investigational monoclonal antibody, otilimab, can help severely ill COVID-19 patients aged over 70 who experience an overreaction of their immune system.

At the heart of infection prevention No 1 disinfectant wipe in the UK National Health Service

NEWS

Priory expands its mental health provision in the Middle East

U

K-based Priory Group – the leading provider of behavioural care in the UK – has, (30 August, 2021), opened the doors to its second Wellbeing Centre in the UAE, paving the way for further expansion across the Middle East region. Priory Wellbeing Centre in Al Bateen, which is focused on providing specialist mental health support and expertise, further strengthens the Group’s offering in the Emirate of Abu Dhabi, alongside its extensive provision of dedicated children’s services.

As well as the new Centre’s broad portfolio of mental healthcare support for conditions such as depression, stress, anxiety, eating disorders and self-harm, it will provide comprehensive children’s services including developmental, speech and language, occupational therapy and educational psychology. This will include assessment and treatment of ADHD, Autism, learning disabilities and difficulties and behaviour problems.

Will Goodwin, Chief Operating Officer of Priory Middle East, says: “Following the success of our first overseas Wellbeing Centre in Dubai, and in response to demand, it seemed a natural next step to expand our services further in the UAE’s capital. Since we entered the healthcare market here, we’ve received a huge level of support from government organisations and regulatory bodies thanks to the strong recognition of the need to help de-stigmatise and raise awareness of mental ill health, while providing access to niche medical services for both residents and visitors.

“We hope this new Centre, and its team of highly experienced medical professionals, will allow our services to be accessed by a wider population and act as a further stepping stone in the expansion of our healthcare and education services across the region.”

Additional key features of the Abu Dhabi Wellbeing Centre include: •

A highly experienced team of psychiatrists, psychologists, speech and occupational therapists offering support in a

SEPT.OCT 2021

38

• • •

number of languages, including Arabic and English Dedicated specialist speech and language and occupational therapy rooms Children’s assessments and interventions to support child development 19 consulting rooms

Will Goodwin adds: “The Middle East offers one of the most exciting and dynamic healthcare markets in the world and we are thrilled to be able to share our vast expertise to ensure patients - both adults and young people alike - receive the very highest levels of care and support.”

Dr Ateeq Qureshi, Medical Director at the new centre, says: “Mental ill health is not discriminatory and can affect us all at some point in our lives, regardless of age, gender and situation. We have a straightforward vision; to provide our patients with the best possible care and experience.

This major new health facility will enable our team of expert health professionals to ensure patients receive the highest level of support and care and support them on their journey to recovery.

“We have made careful adaptions to ensure the culture and care provision within the new Wellbeing Centre reflects the local environment and we hope more people in the region will recognise the equal importance of looking after both our physical and mental health, and seek appropriate help when needed.”

THE NEW FACILITY EXTENDS THE PRIORY’S CAPACITY IN THE UAE, WHERE ITS EXISTING FACILITIES INCLUDE A WELLBEING CENTRE IN DUBAI, WHICH OPENED IN 2017, AND ‘AL KARAMAH SCHOOL’, THE FIRST DEDICATED AUTISM SCHOOL IN THE UAE. AL KARAMAH SCHOOL WAS LAUNCHED IN 2019 IN PARTNERSHIP WITH THE ABU DHABI DEPARTMENT OF EDUCATION AND KNOWLEDGE (ADEK).

Sysmex solutions For over 50 years, we have actively set new standards and driven innovation in haematology and our other areas of expertise

XN-Series Haematology

UN-Series Urinalysis

RD-210 Oncology

CyFlow Cube 6 Flow cytometry

Take your haematology to the next level.

Fully automated urinalysis workflow solution.

Advanced platform for analysing lymph nodes.

A compact bench of flow for analysis of single cells and microscopic particles.

www.sysmex-mea.com

NEWS

Corniche Hospital launches new ‘on demand’ patient menu and upgrades kitchen equipment

C

orniche Hospital, part of Abu Dhabi Health Services Company, (SEHA) – the UAE’s largest healthcare network, has recently upgraded its patient menu and equipped its kitchen with the latest technology in efforts to improve overall patient satisfaction and elevate the inpatient experience.

Dr. Khawla AL Nasseri, Acting Chief Operations Officer, Corniche Hospital, said: “Corniche Hospital is wholly committed to providing women and newborns with an excellent holistic experience during their stay at our facility. In addition to our provision of world-class healthcare and treatment services, we recognize the importance of nutrition as an extremely important aspect of their recovery journey. The new “A la carte” menu and the latest technology allow us to provide nutritious food to our patients at their preferred time while we strictly adhere to any and all diet restrictions and preferences.”

Marwa Abdel Nasser, patient at Corniche Hospital, said: “As a new mother, eating healthy

SEPT.OCT 2021

40

and nutritious food and resting are integral elements to my recovery. I was extremely pleased with the service I received at Corniche Hospital, which almost felt like I was at a hotel. The menu was easy to navigate with English and Arabic options and a wide variety of choices to select from. My meal was delivered within half an hour just as I requested, it was hot, delicious and the perfect quantity.”

SEHA FACILITY ENHANCES HOLISTIC PATIENT EXPERIENCE BY EXPANDING MENU AND ELEVATING ITS ACCESSIBILITY.

NEWS

Valiant Clinic and Hospital offers luxurious touch to healing with the opening of VIP inpatient wing with en-suite facilities to ensure the full comfort of patients as they recover from their medical procedures. Each inpatient room offers a living area and breakout area to offer a space for entertainment, dining and resting for our patients, their family, and friends, all accompanied by breathtaking views of the city.

V

aliant Clinic and Hospital, a leading multi-specialty boutique hospital in Dubai, has now launched its new state-of-theart VIP inpatient wing featuring five luxurious rooms. These rooms come with the touch of a hotel experience, to compliment Valiant’s worldclass care and service offering.

THE VIP INPATIENT WING COMPRISES MODERN ROOMS WITH EN-SUITE FACILITIES.

Located on the second floor of the hospital, the VIP inpatient wing comprises modern rooms

Soliman El-Matbouly, Chief Operating Officer at Valiant, said: “Valiant is consistently looking for ways to make our valued patients more comfortable while providing them with excellent healthcare services and guiding them to recovery every step of the way. The new VIP inpatient wing is a testament to this mission. It also enables us to transform the patient experience and take it to the next level in keeping with our goals.”

Led by a world-class team of specialists, Valiant Clinic and Hospital is a luxurious medical facility that aims to set new benchmarks in the healthcare sector through access to world-class medical care and consistent wellness journey monitoring.

Abu Dhabi approves 77 home-care service providers and new care model

A

bu Dhabi health authorities have approved 77 home-care service providers in the emirate, which can continue to serve more than 4,000 patients.

“The DoH is committed to updating and implementing advanced models of care that enhance the efficiency of the sector and contribute to healthcare services, in accordance with the highest international standards. We continue to improve the healthcare sector to guarantee that residents receive high-quality services that are readily available and that ultimately enhance their experience. The emirate’s advanced models of care will ensure that residents

SEPT.OCT 2021

42

THE APPROVALS WERE ANNOUNCED

BY THE SECTOR REGULATOR, THE DEPARTMENT OF HEALTH (DOH), ALONG WITH AN UPDATED MODEL FOR HOME-CARE SERVICES.

have continued access to services by certified, experienced and qualified specialists,” said Dr. Jamal Kaabi, the DoH undersecretary.

“The updated model of care for homecare services, one of the most comprehensive models of its kind globally, is a testament to the DoH’s continuous efforts in enhancing patient journey. Our top priority is to continue to advance the health and wellbeing of residents through patient-centered and timely services.

The model for home care services adheres to global best practices, procedures and policies, whereby performance indicators are continuously monitored in order to ensure patient safety,” Dr. Al Kaabi added.

SafetyPort

Every bed will be connected

Ready to prevent

100 % of bed related falls1

Using integrated bed sensors allows continuous monitoring of the main safety features of all the beds in a ward. Contactless technology pairs bed data with the patient’s EMR data.

SafetyPort reduces the cost of injuries

Improved patient safety

€124 389/year Can be saved by equipping a 100-bed facility with beds beds that have SafetyMonitor installed2

Enhanced Prevention

Intuitive user interface

HL7 v2 standard

of the risk of falls

compatibility

1 Based on 6 month field test at the University Hospital Vinohrady – Department of Anaesthesiology and Resuscitation II 6 month field test at the Medizine Hochschule Hannover – Department of Neurology.

Nurses confirmed that SafetyMonitor did help prevent up to 5 falls. No falls were documented during the period of field tests.

2 Hoffman, et al. Claims-based Identification Methods and the Cost of Fall-related Injuries Among US Older Adults. Medical Care. Volume 54, Number 7, July 2016.

@LINETMEA

www.linet.ae

NEWS

New WCM-Q program ‘Science for Curious Minds’ inspires high school students

A

new training program launched by Weill Cornell Medicine-Qatar (WCM-Q) brought 20 high school students to the college to learn a wide range of biomedical research skills and explore careers in science and medicine.

The students - all Qatari nationals or longterm residents - began the week with a session on lab safety training, before taking classes in drug analysis and delivery, database search techniques, molecular biology, microbiology and epidemiological modelling. There were also classes on how to structure a scientific paper, the importance of acknowledging previous research, how to contribute to scholarship through research, and a chance to conduct practical experiments in the lab. On the final day of the ‘Science for Curious Minds’ program, the students gave presentations detailing the skills and knowledge they had learned during their week at WCM-Q. The program is aimed at high school students aged 15 and above and is designed to kindle their interest in science by showing them how biomedical research is conducted at a world-class research institute and giving them the chance to gain hands-on experience in the lab. During the program, participating students are encouraged to ask questions freely to help them understand how researchers work and how the discoveries they make are implemented in the real world.

Grade 11 student Almayasa Ashkanani, 15, of Michael E. DeBakey High School for Health Professions, said: “The program has been really great, especially getting to meet the professors, who are so knowledgeable, and doing practical work in the lab, which is something I absolutely love. Chemistry and biology are my favourite subjects at school, and I hope to be able to study medicine and become a doctor, so this program has been perfect for me. It has also been great to be around like-minded students who also have a love of science and medicine.”

SEPT.OCT 2021

44

High school students spent a week gaining research skills at WCM-Q on the college’s new ‘Science for Curious Minds’ program The WCM-Q faculty and staff who took classes during the week were Ms. Reya Saliba, Dr. James Roach, Ms. Henriette Oosthuysen, Dr. Yasser Majeed, Dr. Susanne Awad and Dr. Ghizlane Bendriss.

Dr. Khaled Machaca, Senior Associate Dean for research, innovations, and commercialization, said: “This new program gives us a great vehicle for showing high school students how exciting and rewarding a career in biomedical research can be. We were extremely pleased with the levels of energy, enthusiasm and engagement the students showed and hope that many of them will choose to pursue careers in biomedical research in support of Qatar’s ongoing mission to develop a thriving R&D sector in the country.”

THE PROGRAM IS AIMED AT HIGH SCHOOL STUDENTS AGED 15 AND ABOVE AND IS DESIGNED TO KINDLE THEIR INTEREST IN SCIENCE

BY SHOWING THEM HOW BIOMEDICAL RESEARCH IS CONDUCTED AT A WORLD-CLASS RESEARCH INSTITUTE AND GIVING THEM THE CHANCE TO GAIN HANDS-ON EXPERIENCE IN THE LAB.

‫َر ْبط الصحة‬ ‫والتعليم‬ ‫والبحوث‬ Linking health, education and research

.‫ لكل مريض من مرضانا‬،‫وفعالة‬ ،‫ وحانية‬،‫تقديم أفضل رعاية صحية آمنة‬ َّ Providing the safest, most effective and most compassionate care to each and every one of our patients.

www.hamad.qa

NEWS

Roche Diagnostics appoints new General Manager for the Middle East “It is an honor to take on this role. The healthcare sector in the region has been on a steady upward trajectory, owing to the leadership’s continuous effort in creating superb infrastructure as well as access to the latest in-vitro diagnostics. We will continue to support the region by working with our network of partners towards enhancing the quality of healthcare across the public and private sectors, and a continued patient-centric approach”, said Guido Sander, General Manager, Roche Diagnostics Middle East FZCO.

Guido Sander

R

oche Diagnostics Middle East FZCO today announced the appointment of Guido Sander as General Manager for the Middle East.

Guido Sander has spent over 20 years with Roche around the world and last served as Head of 11 high-growth markets across Asia Pacific (APAC) where he led a diverse team of more than 950 employees, serving 2.3 billion people and positioned Roche Diagnostics as a market leader in APAC region. Guido Sander will succeed Harald Wolf, who has retired after serving the company for over 30 years, in driving business growth and addressing customer and patient needs in the Middle East. He will work towards supporting the transformation of healthcare in the region through long-term partnerships.

“We are delighted to welcome Guido Sander in his new role as General Manager for the Middle East. Guido has been passionate about helping countries improve access to healthcare and address unmet medical needs through our innovative diagnostics solutions. He is also a genuine people leader and I am very confident that he will further drive better health outcomes across the Middle East.” said Bernard Colombo, Head of Europe, Middle East and Africa, and Latin America (EMEA-LATAM) at Roche Diagnostics.

SEPT.OCT 2021

46

Guido Sander joined Roche in 2002 as Strategic Project Manager in Mannheim, Germany.

He has held various leadership positions at Roche Diagnostics across the EMEA-LATAM and APAC regions, including General Manager of Portugal and India respectively, before assuming his former role in 2016.

GUIDO SANDER, SEASONED DIAGNOSTIC INDUSTRY LEADER AT ROCHE, TO SUCCEED HARALD WOLF AS GENERAL MANAGER.

Roche Diagnostics in the Middle East (RDME) RDME has taken the unprecedented step of being the first IVD Company to have a Management Centre in the Middle East. RDME has extended its ownership of the entire supply chain, quality control and customer support all the way into the centre of the region through the appropriate channels. This base of operations reinforces the commitment to global Roche standards and is driven by a full team of vastly experienced specialists offering a complete portfolio of services through the appropriate channels. With this regional empowerment, RDME has moved its leadership and decision-making closer to its customers and distributors. These investments allow Roche Diagnostics Middle East to develop from being a supplier into becoming the preferred IVD partner for its customers.

RDME offers comprehensive expertise through the relevant and appropriate channels in 16 countries: UAE, Saudi Arabia, Iraq, Iran, Qatar, Kuwait, Bahrain, Oman, Yemen, Syria, Jordan, Palestine, Lebanon, Egypt, Libya and Maldives. For more information, please visit www.roche-middleeast.com.

WITH OVER 20 YEARS OF EXPERIENCE IN DEVELOPED & HIGH GROWTH MARKETS, SANDER TO SUPPORT HEALTHCARE TRANSFORMATION ACROSS 16 MARKETS IN THE MIDDLE EAST.

ARTICLES

Errors in healthcare organizations occur due to system and process, why investigating individual errors…

By Mrs. Mary Khoury RN, Masters in Quality and Management Healthcare Organizations, CPHQ, Quality Auditor and Coordinator for Hospital Accreditation Ministry of Public Health, Lebanon

H

uman errors are inevitable in complex systems like hospitals while heavy workload and stress increase errors. Managing these errors needs significant involvement while the commitment of leaders and patient safety culture shall be a priority.

Accountability starts with leadership through the creation of a sustainable, resilient and efficient system and process free from quality defects, deficiencies, duplication of efforts and variabilities that are failures in the system.

The hospital shall use a defined and standardized process for identifying and managing errors. Standardization of the practices throughout the organization and creation of a non-punitive, blameless environment and culture are evident through continuous trainings for employees, learning by practice and teaching rather than blaming them and therefore, encouraging reporting of errors to develop proactive activities and mitigation strategies to reduce their occurrence in the future.

SEPT.OCT 2021

48

Leaders are responsible for monitoring the effectiveness of the actions with clear and defined follow-up for possible system redesign.

A long-term commitment to the process with alignment at the start is critical before it gets tough. Decisions by leaders should be based on reliable and accurate data or performance measures along with effective benchmarking to create an efficient system.

Guidelines, algorithms, clinical pathways and Standard Operating Procedures can decrease the unnecessary levels of care, length of stay, cost and therefore, improve the appropriateness of services provided and decrease errors.

Quality is appreciative by the employee and perceptive by the patient. Errors can be preventable, strengthen your system and process, appreciate your employees and respect their team contributions and engagements to create a commitment to the organization.

ACCOUNTABILITY STARTS WITH LEADERSHIP THROUGH THE CREATION OF A SUSTAINABLE, RESILIENT AND EFFICIENT SYSTEM AND PROCESS FREE FROM QUALITY DEFECTS, DEFICIENCIES, DUPLICATION OF EFFORTS AND VARIABILITIES THAT ARE FAILURES IN THE SYSTEM.

BRINING THE CLINIC TO YOU The smart tele-health platform for remote care in patients homes, employers and rural communities.

Mini kit

Florance powerd by

www.doctory.me

NATIONWIDE CHILDREN’S HOSPITAL WORLD-CLASS PROGRAMS. TRAILBLAZING RESEARCH. PERSONALIZED CARE. Columbus, Ohio, may feel like a world away, but our faculty, researchers and facility have earned international reputations for expertise in rare and complex conditions. Our Cardiovascular team is leading groundbreaking development of a biodegradable tissue-engineered vascular graft for children with congenital heart defects. Our multidisciplinary Center for Colorectal and Pelvic Reconstruction excels in advanced care for even the rarest congenital disorders, motility issues, fecal incontinence concerns and more, for patients in more than 60 countries. And the powerhouse team at the helm of our Neurosurgery and Neuro-Oncology programs excels in both leadership and collaboration in multinational cancer research. When you’re here, you are the center of our attention. Come to Nationwide Children’s —nothing but the best in care, in an accessible, cosmopolitan city.

Reach out to our Global Patient Services team to find out why we should be your new global destination for complex care.

Learn more, refer a patient or plan a trip: NationwideChildrens.org/Global-Patient-Services GlobalPatientServices@NationwideChildrens.org +1 614 362 9127 Nationwide Children’s Hospital, Columbus, Ohio – USA

W295713

AMERICA’S SECOND

LARGEST CHILDREN’S HOSPITAL

* Based on CHA survey of utilization and financial indicators

#Hospotel

#Hospotel Services When the patient turns into a guest and recovery becomes a pleasure

I

n the context of patient care and health in all its aspects, the concept of hospitalization around the world has shifted and taking care of the patient's well-being and psychological comfort and health is now a priority. Recent American studies have shown the importance of the patient’s psychological comfort on his health and the speed of his recovery. The fear of hospitals or considering it a place for the ill only, reflects negatively and to a large extent on the entire hospitalization process. Hence, the idea of turning the hospital into a place of comfort and relaxation with healthcare pro-

SEPT.OCT 2021

52

THE NEW APPROACH THAT HOSPITALS ARE STARTING TO ADOPT IS PATIENT SATISFACTION. JUST LIKE RESTAURANTS AND HOTELS FOR THE CUSTOMERS.

vision, made the idea of going ​​ to the hospital more acceptable, and the recovery process more effective and easy.

Surveys and data have shown that anyone entering a hotel feels how important he is. This feeling gives him a certain comfort and satisfaction. Since the institution and the service provided were originally found to achieve maximum comfort and positivity, hospitals have been seeking for a while to adopt and apply this concept in order to ensure both healing and comfort for the patient, based on the result of

#Hospotel

The question was: What does the patient want?

Besides implementing the strategies used in the guest service industries, another aspect of adopting patient-centered care is the focus on consumers and their experiences that is also the core value of service design. Hospital administrators understood the communicative power of work environment cues from the customer's point of view rather than that of the architect or manager. Studies give this example: When you enter a hotel, you feel that you are considered an important person, while when entering a hospital, you feel that you are just a medical condition that requires hospitalization and treatment. Given that the patient deserves to be honored and likes to be given attention, the care has expanded to become a hospotel bringing luxury, comfort and healing together.

Studies confirm positive outcomes

the numerous studies conducted in this field.

Studies also found that some differences between the preferences of “less healthy” and “healthier” patients, with the less healthy patients willing to pay, on average, 13% higher outof-pocket expenses for hotel-like hospital rooms than the healthier patients. Wealthier patients who are hospitalized for longer periods and are more financially secure are more likely to request hotel-like hospital rooms, which presents an opportunity for hospitals to use hotel-like “sale” techniques for this group of patients. The new approach that hospitals are starting to adopt is patient satisfaction. Just like restaurants and hotels for the customers. Accordingly, researchers and healthcare providers have sought to understand the dynamics of the total product from a marketing perspective. The focus on the patient experience has led healthcare providers to look at the service as it is offered in other industries.

PSYCHOLOGICALLY AND PHYSICALLY ATTRACTIVE ENVIRONMENTS.

Based on this concept, information that patient-centered care in the hospital environment is emerging more and more, and that a new generation of healthcare facilities will be significantly different from today's familiar institutional models. The factor that lies behind these new developments, known as evidence-based design (EBD), derives from a number of fields of study including neuroscience, developmental biology, neuroimmunology and environmental psychology while focusing on the idea that designing this type of luxury care can improve the built environment and the quality of healthcare.

Research indicated that well-designed physical settings play an important role in making hospitals safer and more healing for patients and better places for staff to work and be productive. The research also supports the idea that creating healing environments through EBD makes hospitals less stressful, promotes faster healing for patients, and improves well-being for families. On the other hand, the medical staff, including doctors, nurses and administrators, work in a better atmosphere and higher psychological comfort, thus achieving greater productivity.

Research found that satisfaction with the working environment and hospital stay, which was obtained through various sources such as interior design, architecture, service, privacy and

53

#Hospotel

the surrounding environment, was a significant indicator of patients' overall satisfaction with the hospital experience.

A study of patients with pneumonia found that one standard pattern of increased hotel-like amenities in a hospital increased demand by 38.5 percent, on average. Whereas the request based on other clinical criteria was significantly less responsive.

A new way of delivering hospitality and hospitalization Hospitals are now beginning to create settings that provide patients with a sense of hospitality. Some hospitals are taking healthcare to a new level of luxury; they are competing for wealthy clients who want psychological comfort and welfare wherever they are. These patients are fully pampered from elegant high-thread bedding and marble bathrooms to restaurant-like menus and private concierge services.

This is changing the healthcare scene and generating a better work environment supported by smart decisions.

There is a growing acceptance of the idea that success in both healthcare and hospitality depends on the fundamental principle of developing a culture of respect and the appreciation of all stakeholders.

Not only do healthcare providers benefit from design ideas in the hospitality industry, but also from a hospitality approach that focus on a culture of service. A customer-centric culture provides high-quality service across industries (including healthcare) and is a factor that goes beyond critical customer service skills.

Creating hospotels by including hotel-like amenities together with product (design) and service dimensions is becoming attractive.

Patients who stayed in hotel-like rooms received higher assessments for doctors and nurses and for overall service performance. Creating more psychologically and physically attractive environments had a ripple effect on patient satisfaction, both during and after their hospital stay.

The patient's evaluation of hospotel services showed that those who understood the importance of providing better customer service, in terms of courtesy, speed and cleanliness,

SEPT.OCT 2021

54

In the past few years, there has been an ever-expanding new concept of compensation for hospitals and doctors called “value-based purchasing” or “payfor-performance”. This requires mandatory reporting of patient experiences through the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. Hospitals with more comfortable, safer and more patient-centered environments are rated and approved by patients in this survey. The guaranteed welfare and distinguished service may have a significant impact on the patient's choice of hospital, which in turn affects its market share and raises its financial outcomes.

indicated significantly higher levels of satisfaction. Patients view their hospital rooms as an integrated experience, a bundle of features, and do not evaluate each element individually.

Therefore, design innovations focused on the patient experience in the hospital room rather than the hospital facility as a whole.

Top-notch services at a limited cost This shift in focus may not include largescale capital investment and significant financial gain. Spa services with state-of-the-art bathing facilities (such as high-quality towels, soap, shampoo and toiletries), as well as an in-room salon, may not add significant sums to a hospital's profitability, but they inevitably increase patient satisfaction. Food and beverage services (kitchenette including refrigerator and coffee maker) and room service upon request may improve the patient's attitude. Artwork on the walls and colorful wall designs add to the ambiance rather than the costs, especially when local artists and art students are involved in the space planning and design.

While luxury bed linen may not meet all healthcare needs, it does of course affect patient comfort and satisfaction.

For instance: •

•

•

•

Smart room technology including patient health monitoring and a personal entertainment tablet that may ease patient concerns about their current medical condition.

Concierge services provide patients with flexibility and a sense of control when deciding on foods, beverages and activities.

Adopting a trained healthcare staff to deal with patients. Healthcare personnel trained by hospitality industry professionals can guide the medical staff on how to treat their patients in a pleasurable and reassuring manner in a variety of situations and environments.

Providing aromatherapy and mood lighting; the opportunity to control part of the hospital environment may be

#Hospotel

•

•

•

reassuring, indicating that recovery is possible.

One room for each patient to prevent cross-contamination that often happens to patients or their companions in traditional hospitals.

Psychological comfort in the hospital stay contributes to a speedy recovery.

Feeling like you are going to the hotel and not to the hospital helps a lot in providing psychological comfort.

Studies have proven the importance of hospotels in improving the quality

A CUSTOMERCENTRIC CULTURE PROVIDES HIGHQUALITY SERVICE ACROSS INDUSTRIES (INCLUDING HEALTHCARE) AND IS A FACTOR THAT GOES BEYOND CRITICAL CUSTOMER SERVICE SKILLS.

of hospitalization, whether for patients, doctors, nurses, or insurance company transactions while covering medical business. Everyone knows the importance and impact of work stress on the performance of the doctor and the medical team, which is reflected on the quality of service for the patient.

A revolution in the hospitalization world Hospitals can benefit from providing hotel-like features not only in terms of competitive

55

#Hospotel

advantage but can also provide a way to improve patient experience and satisfaction while boosting revenue through a hotel-like pricing strategy.

Regardless of the details, making patient care environments less scary and more welcoming is an important part of the health process. It is recognized that the guiding principle should be patient safety and well-being although some experts believe that the current trend of turning patients into “customers” or “consumers” is misleading. Unfortunately, some healthcare executives are slow to accept change and this may be because they have invested heavily in the status quo.

A report from the Norwegian Knowledge Center for the Health Services talks about the impact of hospotels on hospitals and patients, saying: In Norway, patients hotels market themselves as an option for inpatients that do not need medical attention 24 hours a day and as a respite in treatment. A patient hotel can offer patients short distance to expertise and treatment if necessary, while the hospital frees a bed for patients with greater need of treatment. A patient hotel can be a suitable accommodation

SEPT.OCT 2021

56

HOTEL-INSPIRED AMENITIES ALLOW HOSPITALS TO OUTPACE COMPETITORS, WHILE INCREASED SERVICES COULD IMPROVE HEALTH OUTCOMES IN MANY HOSPITALS, SOME OF WHICH ARE EVEN BEGINNING TO LIFT STRICT LIMITS ON ICU VISITS.

for patients before, during, or after a hospital stay. In connection with the economic considerations in the regional health authorities, a review about the effects of patient hotels would contribute to a clarification to whether to increase the investments in such facilities.

The Knowledge Centre received a commission from South-Eastern Norway Regional Health Authority, Department of Service Development and Interaction to summarize the knowledge on effect of patient hotels. The effects of patient hotels should be measured for both the hospital, in terms of costs, but also for the patients, in terms of safety or satisfaction. In the project patient hotels should be compared with other types of accommodation. The project was not limited to studies that compared patient hotels with inpatient stay, but all other accommodations without extensive treatment, also stay in their own home. This pattern adopted in the Arab world, has proven to have revolutionized the world of hospitalization, and promises a brighter future to serve the patient, the doctor, the investor and the healthcare sector in general.

RANKED AMONGST TOP 100 WORLDWIDE HIGHEST RANKED HOSPITAL IN THE MIDDLE EAST ONLY HOSPITAL RANKED IN LEBANON

57

#Hospotel

“OUR PATIENTS ARE OUR GUESTS, WE TRY TO MAKE THEM FEEL AT HOME RATHER THAN BEING IN A HOSPITAL.” SEPT.OCT 2021

58

#Hospotel

A

cibadem was a small district hospital in the beginning. We named our hospital after the name of a district of Istanbul.

Today, this name is a well-known global brand in the healthcare sector. Now, Acıbadem operates in 5 countries, namely Turkey, Macedonia, Bulgaria, Serbia and The Netherlands with 22 hospitals and 18 outpatient clinics. In addition to hospitals and outpatient clinics, we are represented in 22 different countries with 36 Health Point information offices. Acıbadem has approximately 21.000 employees, including 4.000 doctors and 4.200 nurses.

We provide services to 5 million people in a year. Acıbadem Healthcare Group grows and develops rapidly both in Turkey and abroad. The Group creates an ecosystem with its business model in a very short time. The driving power of our overall growth strategies is our motivation to act in line with the desire of innovation and perfection with both our business model and our employees, who had already adopted this model, while precisely focusing on patient satisfaction and safety. Acıbadem has blazed many trails and successful works both in Turkey and international field with this culture. Growing is only one of them.

We believe that, our patients are our guests so we try to make them feel at home rather than being in a hospital. In order to do that we mainly concentrate on the healing environment, functional patient flow and patient safety.

As Acıbadem Healthcare Group, we keep creating healing environment for patients, their relatives and our employees with evidence-based design approach. The design criteria aim to create a building that integrates the latest architectural quests, functionality and health technologies. The forest and sea view are also maintained in the interior solutions of the healing design psychology; the glass has been used up to the front, and also natural light has been carried to the inside of the bathroom.

59

#Hospotel

SEPT.OCT 2021

60

#Hospotel

Extensive corridors and waiting areas are separated from each other to increase the level of comfort and to ensure patient privacy. Vertical and horizontal circulations for patients and employees were arranged separately from general circulation areas. The elevator area for service and patients is planned in a region where can be reached from all the medical departments of the hospital in the shortest distance. This is an advantage for logistics of medicine, food, laundry and wastes.

The principal component of our culture is based on the functional patient flow. You can see this clearly at the first point when you arrive to our hospitals. We are known for our hospitality, our patients are our guests and we try to make them feel at home rather than being in a hospital. We know that it is very important to deliver medical and nonmedical services with highest quality to make patients feel at home.

In order to do that, we have developed a 360° model ecosystem that is focused on patient flow to meet all needs. This model was so striking that JP Morgan, one of the important global investment banks, presented this model as an example to the world in 2007. A component of this ecosystem is an integrated structure that provides the patients with necessary services at hospitals. The Healthcare support Institutions within the ecosystem are working hard to be able to continuously improve the patient flow. Acıbadem Project Management develops turnkey hospital establishment projects. Acıbadem Labmed, Labvital, LabCell offer a wide range of services including pathology, food control, stem cell and cord blood bank within the laboratory framework. Acıbadem Technology develops and improves inhouse softwares including “Hospital Information System”. APlus addresses the hygiene, laundry and catering requirements of hospitals and Acıbadem Mobile provides emergency and home care services outside of hospitals. We are proud that, while these support institutions are providing

61

#Hospotel

the highest quality services in Acıbadem Healthcare Group, they also produce services to meet needs of major international brands.

Hospitals are active 7 days 24 hours and the patient safety is a key element for patients and employees. It will be much easier, comfortable and safer to provide health services in buildings where teams are aware of all the needs of this dynamism. On the other hand, the requirements of the building, (circulation, technical infrastructure, logistic processes) the content and requirements of the health services provided in that building should also be in line. For example; the needs of patients from a cancer center or neurology patients, and the establishment of a gynecological and maternity care provider is entirely different. We highly focus on the different disciplines that are serving under the same roof with minimal error and mistake. One of the most important features that make a difference in patient safety is the operating room environment.

The operating room has been made with modular panel system. Because of the motivation and sustainable hygienic characteristics of the staff living throughout the day, the colored decorative glass is preferred for the panel coating.

For the first time in Turkey and very unique all around the world, Hybrid Operating Room system has been applied which has three different diagnostic units (3 Tesla MRI, 128 slice CT, robotic angio) in sterile area where connected to three operating rooms. Thanks to the surgery under real time imagining structure, brain surgery, interventional radiology, cardiovascular surgery, interventional cardiology, orthopedics and traumatology, cranio-facial surgery urology branches, cancer surgery, 3D trauma surgery are more practicable, efficient and secure. In order to increase the working efficiency of the operating rooms, paranesthesia boxes have been planned in the operating rooms. A central sterilization and medical consumables warehouse were assembled in a common area and a design was prepared for each case with a case cart prepared according to the nature of the case in terms of the operational efficiency.

Acıbadem Healthcare Group has been designed according to high healthcare standards in such

SEPT.OCT 2021

62

#Hospotel

a way as to integrate the beneficial effects of high technology into the functional needs of a patient to ensure patient safety.

To sum up, we believe that, our priority is our patients comfort and safety so that the hospitals are designed considering the healing environment, patient flow and safety. Our investment since 1991 enabled us to create comfortable hospitals with high technology providing all medical and nonmedical services in high quality.

Contact Acibadem Healthcare Group to get free medical opinion from world renowned physicians: www.acibademinternational.com

63

#Hospotel

HOSPOTEL, The future hospital with seamless integration of wellness and hotel

By Dr. Prem Jagyasi, a Times Award-Winning Global Speaker and Certified Corporate Trainer

F

rom my past experience in the healthcare sector, I strongly believe hospitals will need to provide something more than medical services for improved outcomes and patient satisfaction. In comes HOSPOTELS that take a holistic approach to patient well-being with the proper amalgamation of hospitality and wellness services. The future hospitals or HOSPOTELS are likely to implement more cross-sectoral services borrowing from hotels and wellness resorts that will significantly impact the patient’s journey to healing.

Changing mindsets and expectations will drive HOSPOTELS Patients expect to be treated as guests;

SEPT.OCT 2021

64

this has been a vital shift in the overall mindset. In the hospital, a patient goes through an emotional roller-coaster that can impact his/ her treatment and recovery. I have keenly observed, hospitals addressing the patient’s expectations with more emphasis on care, comfort, and convenience factors have experienced better outcomes in all respects.

Today, the need is even more. Assessing patients’ demands and expectations is not easy, but more or less, the following aspects could serve as the baseline.

• A residential feel in the clinic or hospital just as a guest feels in a hotel. No intimidating ambience or the ice-cold mechanical approach of physicians,

CREATING A RELAXING AND TENSION-FREE AMBIENCE IS THE FIRST THING HOSPOTELS WILL FOCUS ON.

#Hospotel

•

• • • •

•

• •

nurses, and non-medical staff.

Seamless services. Zero waiting time for registration, appointment, consultation, diagnosis, treatment, and disengagement from the facility.

More informal communication with a genuine feeling of care.

Facility with wellness vibes, giving the feel that nothing can go wrong.

Keeping touch with touchless services.

Comforting facilities that help in reducing pain and suffering while healing may take some time.

More comfort and convenience for those accompanying the patients. They could be friends or family members.

Enhanced gratification in F&B services.

Improved convenience with end-to-end seamless tech support through apps and connected platforms in pre- and post-hospital stays.

Seamless integration of wellness and hospitality – key HOSPOTEL concept HOSPOTELs will evolve as one of the kind facilities offering cutting-edge treatments, wellness services and the best level of hospitality enabling patients go through an incredible experience.

Key features are likely to be as follows: Taking out the fear and apprehension Creating a relaxing and tension-free ambience is the first thing HOSPOTELS will focus on.

No intimidating treatment rooms, consultation chambers, or testing labs.

So would be the verbal communication, gestures, and body language of all staff including physicians, nurses, attendants, and receptionists that will generate assurance not fear

Good pre-admission experience Prior to admission, a patient has to go through stressful diagnostic tests and assessments. HOSPOTELs will provide valuable information about the patient’s health status, upcoming admission, treatment procedures, attending physicians, and other arrangements

tailor-made to meet his/her specific needs. The aim is to minimize dread and set realistic expectations among patients.

Wellness design and architecture A fresh, warm, and cosy feeling with aesthetically pleasing biophilic features will make up the core of the HOSPOTEL design.It could be like including a pool, walking track, prayer and meditation centre, healing garden, green open spaces for relaxation, fitness centre, or even a small wellness spa. Eateries, waiting places, and lobbies will have unique designs with added comfortable features instead of usually-observed crowded spaces.

Great amenities I have seen how great in-room services can make a patient feel at home and reduce his/her anxiety. It could be like bedside infotainment, easy access to wi-fi, cable connections, music, and last but not the least, convenient parking facilities.

HOSPITAL FOOD NEED NOT BE BLAND OR TASTELESS SINCE IT IS MEANT FOR PATIENTS. ON THE CONTRARY, THEY WILL BE SERVED HAPPINESS WITH CUSTOMIZED FOOD PLANS CREATED BY RECOGNIZED CHEFS. DINING SPACES ARE MORE LIKELY TO GIVE THE FEELING OF A DECENT RESTAURANT RATHER THAN A CRAMPED CAFETERIA.

Family-oriented ambience It is not the patients who should feel calm and relaxed, but also the family members accompanying them. They may not be the direct clients but could play a great role in healthcare decision-making especially in hospital selection.

HOSPOTELS can accommodate a library, entertainment spaces, kids' spaces, an extra guest bed, infotainment facilities to make accompanying visitors feel at ease during their visits or stay in the facility.

Stress and anxiety management programs Integrating guided mind-body programs into medical treatments provides the much-desired mental and emotional support to patients.

HOSPOTELS can be exemplary in this.

Special services will make a big difference I feel, Hospotels can curate mind-body engaging indoor and outdoor activities or alternative therapies under professional supervision to facilitate healing and recuperation.

65

#Hospotel

Genuine empathetic communication Humane and empathetic communication matter in boosting patient’s mental well-being.

It starts from receptionists, attending physicians to all staff interacting directly or indirectly with the patients. When patients wait with bated breath counting minutes in apprehension, warm and comforting communication can make a big difference. They will generously give higher ratings for good communication and empathy.

Integrated wellness catering Hospital food need not be bland or tasteless since it is meant for patients. On the contrary, they will be served happiness with customized food plans created by recognized chefs. Dining spaces are more likely to give the feeling of a decent restaurant rather than a cramped cafeteria.

Post-discharge care In my opinion, patients deserve a hassle-free time-saving discharge procedure. When they are eager to go home, spending hours on discharge is punishing. Caregivers should be prompt in

SEPT.OCT 2021

66

handing out follow-up schedules and post-treatment care programs. Post-discharge phone calls to check on the patient’s condition can boost patient satisfaction significantly.

Caregivers need to don many hats There is a need for specially-trained caregivers who can don several roles of a nurse, physiotherapist, medical aid, or counsellor as and when required. When you think of uplifting hospitality standards, caregivers should play a crucial role.

Monitoring patient satisfaction and collecting feedback HOSPOTELS should regularly monitor patient satisfaction levels and their feedback.

This is crucial to maintain a high occupancy rate.

Internet literacy is growing among patients who will check reviews, and feedback before making a choice. Finally, Hospotels will have to create the right working ambience and culture to foster a great connection between the hospital staff and patients to enhance performance and reputation.

HOSPOTELS CAN CURATE MIND-BODY ENGAGING INDOOR AND OUTDOOR ACTIVITIES OR ALTERNATIVE THERAPIES UNDER PROFESSIONAL SUPERVISION TO FACILITATE HEALING AND RECUPERATION.

#Hospotel

BD CAN HELP YOU GET YOUR MEDICATION MANAGEMENT TECHNOLOGIES ON THE SAME PAGE, AND YOUR TEAM DOING WHAT MATTERS MOST. At BD, we know medication management is incredibly complex.

Aligning people, technologies and systems to get a single medication safely to a patient is daunting. But there’s a better way, one that enables IT professionals to get all the players, parts and processes on the same page. At the heart is our integrated approach that connects our medication management solutions with each other - and with the EMR. The result? Improved efficiency and greater visibility across your enterprise, so your clinicians can get back to what matters most: your patients. Discover medication management that takes less management. Discover BD.

Discover connected medication management by visiting bd.com/connected-tech BD, the BD Logo and HealthSight are trademarks of Becton, Dickinson and Company or its affiliates. © 2021 BD. All rights reserved. 1910004695 (04/20) BD-17226

67

ARTICLES

Employing the Power of AI and Interoperability to Reduce Sepsis Mortality

By Dr. Penny Cooper, DHSc, Data Scientist at Augusta Health

A

ugusta Health is a community hospital nestled in Virginia’s beautiful Shenandoah Valley focused on improving the health and well-being of our community. The statewide sepsis mortality rate in Virginia is 12.7%, while at Augusta Health it is 4.76%. We have been able to achieve a significantly lower sepsis mortality rate by employing the power of artificial intelligence (AI) and communication technology. So far, we have saved 355 lives that could have been lost to sepsis.

Mortality from sepsis increases by as much as 8% for every hour that treatment is delayed.

Our nurses are highly trained and are skilled at

SEPT.OCT 2021

68

detecting early symptoms of sepsis based on standard indicators. They are also very busy.

Aware of how many patients our nurses care for and the many tasks nurses juggle at once, our leadership team wanted to provide our nurses with additional support. Among the resources provided was a program to identify symptoms of sepsis sooner.

We formed a Sepsis Team and Taskforce in 2016 to take advantage of AI and communication capabilities and give our nurses an extra set of eyes to automatically review patient data and alert them as soon as a patient shows signs of being septic. Our goal was to detect and treat sepsis as early as possible and save lives.

WE HAVE BEEN ABLE TO ACHIEVE A SIGNIFICANTLY LOWER SEPSIS MORTALITY RATE

BY EMPLOYING THE POWER OF ARTIFICIAL INTELLIGENCE (AI) AND COMMUNICATION TECHNOLOGY.

ARTICLES

Automated Process for Sepsis Risk Detection and Alerts We began by using the four traditional criteria to identify sepsis – a temperature greater than 38°C, heart rate greater than 90, respiratory rate greater than 20, and an abnormal white blood cell count. In addition, we monitored mean arterial pressure and shock index. Our Sepsis Team and Taskforce then began a retrospective study of the data to determine which variables had the highest correlation to Sepsis.

We used the results of that study as a benchmark for developing an automated process that analyzes and compiles real-time data from medical systems each hour and assigns each patient a score. If the score is above a specific threshold, a sepsis alert is sent automatically to team members caring for that patient.

Team members receive the alert with contextual information on their mobile communication device, which might be a hands-free Vocera Badge or a smartphone running a Vocera app.

System Interoperability Including Real-Time Communication The automated process involves interoperability among three systems: • Our electronic medical record (EMR), MEDITECH • Our predictive analytics tool, which scours critical data in a patient’s record • The Vocera clinical workflow and communication system We considered other sepsis alert tools that flagged potential sepsis cases within patients’ EMRs. However, those tools provide clinicians with sepsis alert flags only when they open the patient’s medical record. By contrast, the system we built alerts the care team immediately on their Vocera Badge or smartphone, without any manual intervention. Sepsis alerts are automatically sent to the right care team to initiate care quickly when early signs of infection are identified.

System interoperability has been key to ensuring the right data with situational information gets to the right clinicians at the right

time. Upon receiving an alert, the assigned staff member immediately screens the patient for sepsis. If sepsis is identified, they begin early intervention.

Saving Time, Saving Lives In the United States, more than 1.7 million people develop sepsis each year, and approximately 270,000 of them die. To decrease mortality rates and increase the likelihood of reversing the damaging outcomes of sepsis, early detection is critical. Hundreds of lives that could have been lost to sepsis have been saved because of our Early Sepsis Alert System; since April 2016 we have been able to save 355 lives.

The work done by our teams at Augusta Health to reduce mortality rates from sepsis has been a collaborative effort. Health Quality Innovators (HQI) named our hospital the Health Quality Innovator for Virginia in the category of Data-driven Care in 2018. U.S. News & World Report recognized Augusta Health as a Best Hospital in the Shenandoah Valley for 2020-21.

We are very proud of these honors and are happy to have the opportunity to share our work with other facilities around the state so more lives can be saved.

HEALTH QUALITY INNOVATORS (HQI) NAMED OUR HOSPITAL THE HEALTH QUALITY INNOVATOR FOR VIRGINIA IN THE CATEGORY OF DATA-DRIVEN CARE IN 2018. U.S. NEWS & WORLD REPORT RECOGNIZED AUGUSTA HEALTH AS A BEST HOSPITAL IN THE SHENANDOAH VALLEY FOR 2020-21.

www.vocera.com/me

69

ARTICLE FEATURES . Emerging Healthcare Technology

Emerging Healthcare Technology How has the nurses’ workplace changed?

T

here has been a lot of talk about how technology can improve patient outcomes, but there is a huge impact on nursing as well. Advantages include greater accuracy, fewer employee infections, and better spread of information. The healthcare industry is relying on technology to make up for the nursing shortage and improve patient outcomes as well. But it's time to stop and assess the impact of healthcare technology on nursing, which is the world's largest healthcare workforce.

Healthcare nursing service providers have many roles, and the nursing sector includes the largest number of workers in this field. For instance, the nursing workforce in a country like the United States is the size of the army.

According to the Bureau of Labor Statistics, there were 4,600,000 female nurses by the end of 2017. Until 2020, the number had increased

SEPT.OCT 2021

70

significantly, but according to the National Council of State Boards of Nursing (NCSBN), there is still a nursing shortage, and this applies to most countries in the world.

Hence, there was a trend to digitize the sector and the use of technology. What were the results?

Continuous Developments The digitization of healthcare and related technologies is accelerating to help solve this staff shortage. The past year has been a successful year for the healthcare IT industry, according to the Semi-Annual Health IT Market Review

by Healthcare Growth Partners. Investments in assistive technology, Internet of Things in healthcare and other healthcare technologies are seeing similar spikes.

Many nursing behaviors have changed over the last 40 years.

THE DIGITIZATION OF HEALTHCARE AND RELATED TECHNOLOGIES IS ACCELERATING TO HELP SOLVE THIS STAFF SHORTAGE. THE PAST YEAR HAS BEEN A SUCCESSFUL YEAR FOR THE HEALTHCARE IT INDUSTRY, ACCORDING TO THE SEMIANNUAL HEALTH IT MARKET REVIEW

BY HEALTHCARE GROWTH PARTNERS.

ARTICLE FEATURES . Emerging Healthcare Technology

71

ARTICLE FEATURES . Emerging Healthcare Technology

As technology advances, many aspects of nursing have improved, with greater accuracy, better patient outcomes, fewer employee infections, and better spread of information.

Technologies such as some types of pumps, electronic graphs, and telemetry monitors used in nursing work have changed a lot. Intravenous pumps automatically control doses and drops, and electronic graphs are replacing the quick, handwritten notes of healthcare professionals.

New technologies are automating business processes and patient safety procedures. Portable telemetry devices make it possible to monitor a patient's condition even if the nurse or patient is on the move.

Nursing experts and designers of the new machines say technology has made nursing specialties at the forefront of specialties.

Today, the nurse’s job is easier, as we have the efficiency of having medical records at our fingertips. The trend towards nursing specialties is even greater thanks to the introduction of technology into this sector. It improved communication, enhanced documentation, introduced evidence-based practices, and led to many high-quality innovations, providing a safer and more efficient work environment. These advantages that accrue to patients are clear. The importance of technological assistance in the daily work of nurses has brought about a clear health revolution.

For example, giving five patients their medication at about 9 a.m. may seem simple and routine, but it's often not so simple. A consultant in health informatics and digital strategy and a professor at Baylor College of Medicine says that there are many cases in which the patient may refrain from taking the necessary medication, or other reasons may prevent this, which affects the patient's health and the level of medical service in general. While the techniques in this field can be invaluable to nurses. When technology in hospital is disabled for whatever reason, it's a huge disruption for a very busy, multitasking nurse, especially when it comes to entering data or determining some information.

The Emirates is an example With the aim of studying the impact of

SEPT.OCT 2021

72

technological development on the practice of the nursing profession, and under the slogan “The Future View of Nursing in the Era of Technological Development”, the Ministry of Health and Prevention in the UAE organized the first nursing conference in 2018. The participants emphasized the importance of providing the latest technical and technological services in various types of healthcare, especially in the nursing sector, given the importance of integrating technology into healthcare services to help nursing staff keep abreast of the latest developments in nursing technology and modern nursing practices. This will allow them to deal with daily challenges, with the introduction of robots in the field of healthcare services, and their success in providing the best results in record time and less human error, in addition to the importance of benefiting from artificial intelligence and advanced technology and utilizing them in developing medical and operational efficiency.

The Ministry of Health and Prevention considers nursing informatics to be one of the vital fields in nursing care at the global level, with the aim of training and guiding nursing staff in the UAE to use the medical information technology in order to improve the level of healthcare

SOPHISTICATED COMPUTING AND MACHINE LEARNING MUST ALSO PLAY A ROLE IN THE HEALTHCARE IOT TO HAVE THE MOST POWERFUL AND SIGNIFICANT IMPACTS ON PATIENT CARE AND OUTCOMES, AND TO MAKE THE WORK OF NURSES MORE INNOVATIVE. SOPHISTICATED COMPUTING REQUIRES DATA PROCESSING CLOSE TO ITS SOURCE.

ARTICLE FEATURES . Emerging Healthcare Technology

provided to patients, in an effort to achieve the Ministry’s strategy to enhance community health by providing comprehensive, innovative and sustainable health services with global standards that exceed expectations for a happy society.

In the UAE, one of the most important initiatives in this field at the regional level is the national initiative to enhance the attractiveness of nursing, which aims to attract national employees with the number and quality appropriate to the community’s health needs, which contributes to providing distinguished healthcare that

suits the country’s environment and culture and helps to implement plans to localize the profession, ensuring a prominent position for the UAE so it becomes at the forefront of the healthcare industry in the region and the world.

There are plenty of advances every day, as tech-savvy consumers bring the Internet of Things into healthcare and nursing through their wearables, apps, and data. This is because many diseases and early deaths are caused by behaviors that can be changed, and specialists assert that technology can change behavior.

TECHNOLOGY IS ALSO USEFUL IN THE EARLY IDENTIFICATION OF HEALTH PROBLEMS, ALLOWING FOR EARLIER INTERVENTION AND BETTER OUTCOMES.

73

ARTICLES

Niagara Health Reduces Number of Injuries in Code White Emergencies by 20% – Staff Feel Safer While They Work

By Sandy Traynor, Workplace Relations Manager at Niagara Health and Stevie Christopher, RPN, Information and Communications Technology System Analyst at Niagara Health

R

ecently, in the emergency department (ED) of one of our hospital sites, a patient became combative with a front-line nurse. The nurse double-tapped the Call button on her Vocera Badge – a wearable communication device – to call a code white, alerting security staff instantly and discretely. The security team rushed to her location, able to hear what was happening on their way to the scene through the Badge, without the nurse needing to say a word to them.

The nurse was unharmed. She said she was grateful she was wearing the Badge.

SEPT.OCT 2021

74

Several years ago, when we were still using VoIP phones for communication, it would have been difficult or impossible for this nurse to call a code white in this threatening situation. Imagine someone needing to pick up a phone, dial a number, and ask for help while trying to defuse a situation or fend off an aggressor.

This powerful story reminded us of why we use Vocera here at Niagara Health, a 949-bed, multi-site hospital organization in Ontario, Canada. We first deployed the Vocera Badge and mobile app that clinicians use on their personal smartphones in 2016. Staff who work in our EDs, mental health units, and medical floors across

THIS POWERFUL STORY REMINDED US OF WHY WE USE VOCERA HERE AT NIAGARA HEALTH, A 949-BED, MULTISITE HOSPITAL ORGANIZATION IN ONTARIO, CANADA.

ARTICLES

our sites find the Badge to be vital in helping them feel safe while they work.

A Unified Approach to Communication In 2015, our leadership team was evaluating solutions that could provide a unified approach to communication across our sites. We also needed a faster, more reliable way to allow staff to call for help and to prevent potentially violent situations from escalating. During the evaluation process, one of our hospital partners in Ontario recommended Vocera because it makes it easy for all members of the care team to communicate and collaborate in real time. It also enables fast response to all codes including code white.

Sandy Traynor, our workplace relations manager, is the driver and advocate of Vocera technology at Niagara Health. She has been instrumental in making sure all the employees who need Vocera devices have them. Stevie Christopher, who is a nurse in addition to being a systems analyst, supports Vocera across the enterprise, training new users and providing support to users of the technology.

Ingrained in Our Workflows Vocera technology is ingrained in our workflows. It enhances efficiency and allows our care teams to focus on patient care. We have peace of mind knowing staff are logged into the Voc-

era system while they’re working because it’s an essential part of how they communicate every day. If a care team member needs to call a code white emergency, we know they’re prepared to do so. The results are measurable: The number of people injured in aggressive incidents since Niagara Health deployed Vocera has decreased by 20%.

Unpredictable things happen all the time in healthcare. Vocera technology helps our staff stay safe, connected, and prepared. We know our staff love it because they have told us, and because they always use it.

Learn About Additional Impact Realized at Niagara Health Vocera technology helps us unify clinical communications across the enterprise and make staff feel safe. It’s also given physicians a standard, secure way to communicate using their own devices. And in the COVID-19 pandemic, it has helped us conserve PPE while minimizing the spread of infectious disease. We invite you to read all about it in our recent case study1.

Sandy Traynor is a Workplace Relations Manager and Stevie Christopher, RPN, is an Information and Communications Technology System Analyst at Niagara Health, a 949-bed, multi-site hospital organization in Ontario, Canada.

IN 2015, OUR LEADERSHIP TEAM WAS EVALUATING SOLUTIONS THAT COULD PROVIDE A UNIFIED APPROACH TO COMMUNICATION ACROSS OUR SITES. WE ALSO NEEDED A FASTER, MORE RELIABLE WAY TO ALLOW STAFF TO CALL FOR HELP AND TO PREVENT POTENTIALLY VIOLENT SITUATIONS FROM ESCALATING.

www.vocera.com/me

Citations https://www.vocera. com/resource/ case-studies/niagarahealth-unifyingcommunicationsacross-enterprise

75

INTERVIEWS

Chief of Colorectal and Pelvic Reconstructive Surgery at Nationwide Children’s Hospital

Richard Wood, MD “Nationwide Children’s Hospital is no stranger to patients traveling to Columbus (Ohio) for colorectal and pelvic reconstruction”

N

ationwide Children’s Hospital, located in Columbus, Ohio, is one of the largest pediatric hospitals and research institutes in the United States. It is consistently ranked as one of America’s top 10 children’s hospitals by U.S. News & World Report, the recognized authority in United States hospital rankings. Richard Wood, MD, is Chief of Pediatric Colorectal and Pelvic Reconstructive Surgery at Nationwide Children’s Hospital and associate professor of Surgery at The Ohio State University College of Medicine. Dr. Wood’s areas of clinical interest are complex pelvic reconstructive surgery including anorectal malformations, cloacal malformations, Hirschsprung disease and the surgical management of severe constipation. He is also widely published in these areas, with numerous peer-reviewed journal articles and book chapters. Hospitals magazine recently interviewed Dr. Wood about pediatric colorectal and pelvic reconstruction at Nationwide Children’s Hospital.

What are the components of a pediatric colorectal and pelvic reconstruction center?

The Center for Colorectal and Pelvic Reconstruction (CCPR) at Nationwide Children’s Hospital comprises a comprehensive team of pediatric surgeons and physicians with special expertise in colorectal surgery, reconstructive urology and gynecology, as well as pediatric gastroenterologists with a specific interest and advanced training in motility disorders. All work collaboratively in a patient- and family-centered care model. Advanced practice providers, nurses and administrative staff also complete a team that meets patient needs and organizes and oversees their care.

What are the most commonly treated conditions?

Most commonly we treat children with an

SEPT.OCT 2021

76

PATIENTS FROM 12 DIFFERENT COUNTRIES HAVE BEEN REFERRED TO OUR CENTER AND HAVE BEEN EVALUATED BY OUR TEAM.

anorectal malformation, cloacal malformations, cloacal exstrophy, Hirschsprung disease, and severe functional constipation. Because we specialize in the most complex reconstructive problems and have extensive experience in re-operative surgery, we serve as a large referral center and see children of all ages at various stages in their care continuum.

How is the program at Nationwide Children’s Hospital different?

Our program is uniquely qualified to care for patients across their life span. We have an extensive team to take care of all aspects of patient needs. We have published outcomes on all aspects of care and integrated quality improvement and patient reported outcomes measures into our care model. In addition, we have instituted a transitional care program, spearheaded by renowned colorectal surgeon, Dr. Alessandra

INTERVIEWS

Gasior, and me, which allows us to care for our patients from birth into adulthood. We also offer long-term follow-up care by an expert team including surgeons, nurse clinicians and advanced practice providers. These teams are dedicated to caring for patients and all their colorectal, gynecologic, and urologic needs.

Are patients willing to travel in order to receive care?

Nationwide Children’s Hospital is no stranger to patients traveling to Columbus for colorectal and pelvic reconstruction. Currently, 60% of our CCPR patients came to us from outside the state of Ohio, USA. We have treated patients from all 50 states and more than 70 countries. We take pride in our ability to gather pertinent medical history prior to a patient’s visit, to create a plan of care up front and consolidate as much testing and surgery that may be needed for each patient during their visit.

We also have a dedicated team within Nationwide Childrens Hospital, called Global Patient Services, who works directly with CCPR to allow for international patients to travel to

Nationwide Children’s Hospital seamlessly for care.

What type of research are you currently publishing?

We place a significant emphasis on outcomes research and have fully integrated research into our care. In just the past seven years we have published more than 120 peer-reviewed journal articles and conducted 130 presentations at national and international meetings. In addition to outcomes research we place particular emphasis on research involving quality of life for patients and families with anorectal and cloacal malformations and Hirschsprung disease. We have reported on quality of life improvement with our bowel management program and recently on the success of using telehealth to be able to offer successful remote bowel management. New areas of research involve genomic medicine and how aspects of behavioral health impact outcomes and care for our patients. We have run clinical trials and have introduced several new surgical techniques and treatment protocols.

WE HAVE A LONGSTANDING AND VERY FRUITFUL COLLABORATION WITH EMMA CHILDREN'S HOSPITAL, IN AMSTERDAM, THE NETHERLANDS, WITH EXCHANGE OF VISITING SCHOLARS, WHICH HAS PRODUCED MORE THAN 40 PEER-REVIEW PUBLICATIONS IN THE PAST 15 YEARS.

To learn more about Nationwide Children’s Hospital and Dr. Wood, visit NationwideChildrens.org/CCPR

77

ARTICLE FEATURES . Laboratory Sample Tubes

Laboratory Sample Tubes Various uses according to the tube cap color

L

aboratory sample tubes are one of the most important tools in any examination, given their high-quality specifications.

Their production requires high accuracy and raw materials with medical classification that conforms with international standards. The manufacture of blood drawing tubes is a giant project that is produced in specific factories and is characterized in the production process. The tubes used differ according to the blood test, and the substance inside each tube varies according to the type of test required. Blood may be collected into a tube containing an anticoagulant, which prevents clotting. The tubes are different in sizes and have different colored caps, and each color indicates the content of the tube.

SEPT.OCT 2021

78

ARTICLE FEATURES . Laboratory Sample Tubes

Types of tubes and cap colors The tube caps used for collecting lab samples indicate their specifications and what they contain, such as the presence /absence of additives, preservatives or coagulants, provided that the type of tube is determined according to the required tests. Preservatives prevent changes in the sample and anticoagulants prevent clotting, in addition to the presence of special vacuum tubes called Vacutainer Tube.

Red cap tubes Red cap tubes indicate that it is free of additives such as anticoagulants, and some of them add silicon or gel in order to reduce the hemolysis process. Such tubes are used in the blood bank and some routine chemical tests and hormones, as they are used in the Serology Department. It contains silica particles inside it to separate the serum or as it is known as the blood serum.

Yellow cap tubes This type of tube contains an anti-coagulant, which is a gel that is placed in a very simple way because it is not concentrated, so that this substance can prevent clotting and separate the serum. This type of tube is used in blood culture specimen collections in microbiology.

Blue cap tubes This type of tube is used in blood clotting tests such as fibrinogen factor test, prothrombin

THE TUBE CAPS USED FOR COLLECTING LAB SAMPLES INDICATE THEIR SPECIFICATIONS AND WHAT THEY CONTAIN, SUCH AS THE PRESENCE / ABSENCE OF ADDITIVES, PRESERVATIVES OR COAGULANTS.

time (PT) and partial prothrombin time (PPT).

Sodium citrate is placed inside the tube, and after the sample is drawn, 7 ml of it is added, and then it is placed on a blood sample of the same size.

Green cap tubes This type of tube is used the least and is for biochemical tests that require plasma heparin or whole blood for analysis. Substances such as sodium or lithium heparin are added to it. It is also used in the Cytogenetics Department, and can be also used in measuring pH, blood gases, electronics, amino acids, and hormones. The volume of the sample to be withdrawn from the patient is 10 ml.

Purple cap tubes It is used in hematology tests, where complete medical analyzes are required for blood analysis. It contains Ethylenediaminetetraacetic acid (EDTA), which acts as an anticoagulant by removing calcium from the blood. It also contains some minerals in the blood, and this is used in the treatment of iron, lead, or mercury poisoning.

Gray cap tubes This type of tube is used for glucose determinations. The tube contains potassium fluoride, which works to prevent glucose concentration, as it stops glycolysis in the blood cells. It also contains potassium oxalate.

79

ARTICLE FEATURES . Breast Cancer

A comprehensive concept in patient care

Breast cancer treatment with a multidisciplinary approach

T

he multidisciplinary approach used in the treatment of cancer in general and breast cancer in particular is the trend of modern medicine to obtain more effective solutions in terms of accurate diagnosis and treatment through the several specialties of physicians who work closely together to reach a treatment protocol catered to the medical condition.

Doctors from different specialties related to the breast cancer treatment try to reach a common decision in treating the patient for optimal results. This is what breast cancer centers and departments provide, as they combine the vast experiences of doctors in terms of specialized skills, state-of-the-art equipment and modern technologies, in addition to the latest treatment methods. Modern centers specialized in treating breast cancer according to the foundations and principles of a multidisciplinary approach, offer a comprehensive concept and new standards in

SEPT.OCT 2021

80

UNIQUE MEDICAL CENTERS THAT GIVE BREAST CANCER PATIENTS NEW HOPE BY PROVIDING THE PERFECT COMPREHENSIVE CARE.

patient care within a variety of services starting with early examination and diagnostic imaging in accordance with the latest equipment, in addition to obtaining a consultation from specialist doctors and setting the appropriate treatment protocol. These centers also provide plastic and reconstructive surgery given its psychological impact, which is reflected in the response to treatment and the speed of recovery.

Integrated Program The patient receives comprehensive care that includes the psychological and emotional aspect along with the appropriate treatment protocol catered to her condition. The goal is to ensure a high-quality service throughout the treatment period, so that comprehensive breast healthcare services are provided in one place using the latest medical equipment and available treatments. After seeing the primary care physician, the patient is referred to a team

ARTICLE FEATURES . Breast Cancer of specialized doctors and based on the initial evaluation and review of previous records, the patient can meet with a breast imaging specialist, genetic counselor, surgeon and oncologist.

This is usually done on the same day, and they all work together to come up with a customized treatment plan as required by each patient's medical condition. We have also established a team specialized in breast cancer, which holds regular meetings to discuss complicated cases and suggest the best available ways to treat those conditions.

The multidisciplinary approach is based on a medical team that includes: • • • • • • • •

Radiologist Surgeon specialized in breast surgery Radiation Oncologist Oncologist Plastic Surgeon Psychologist Breast care nurses Nutritionist

Specialized Nursing Team A FULL RANGE OF SERVICES ACCORDING TO THE LATEST FINDINGS OF MODERN MEDICINE IN THE DIAGNOSIS AND TREATMENT OF BREAST CANCER.

The nursing staff specialized in breast care are an integral part of the health system in these centers. The nursing staff is specially trained to care for patients, provide them with psychological comfort, support and encourage them, in addition to taking care of the patient before and after surgery and educating her about what to expect when returning home.

Psychological Support Within the multidisciplinary approach in caring for breast cancer patients, a psychiatrist is also essential as well as psychologists trained in helping the patient and her family members deal with anxiety and depression after receiving the news of the disease and during the frustrating phase of treatment. The psychological support during this period relieves the patient’s emotional distress and significantly improves her quality of life.

This approach means that this specialized team meets on a regular basis in order to discuss each case and decide on the latest evidence-based treatment for a particular type and stage of cancer, in order to benefit the patient and allows her to follow an integrated breast care program based on different medical perspectives. The oncologist works closely with the surgeon, radiologists, nuclear medicine physicians, gynecologists, endocrinologists, plastic surgeons, physiotherapists, geneticists and psychologists to ensure rapid diagnosis of breast cancer patients, prompt implementation of surgical and medical treatments, and the highest quality of care during all stages of the disease.

Skilled Oncologists Oncologists are pioneers in determining the appropriate treatment protocol, whether chemotherapy, immunotherapy, targeted therapy, or even a combination of two or more types of available treatments. The safest and most effective treatment is determined while helping the patient manage the side effects of chemotherapy so that she can lead a relatively normal life while receiving treatment doses.

81

ARTICLE FEATURES . Obesity Medicine

Obesity Medicine Comprehensive concept of obesity treatment & customized weight management programs

T

here are many diseases and health problems that result from obesity and overweight, which prompted hospitals to establish specialized departments that treat obese patients, as well as medical centers that care for this category and provide them with the necessary consultations along with treatment or surgical plans if the need arises, so patients undergo a diet and exercise program or behavioral treatment that takes into account the psychological aspect.

Hence, “obesity medicine” arose after it was found that it is linked to several diseases that can be prevented or their risks can be reduced by simply eliminating excess weight. Some obese people suffer from health disorders that prevent them from losing weight through traditional methods, and they need medical intervention to determine the cause.

Thus, programs dedicated to weight management were developed within what is now known as “obesity medicine” aimed at helping overweight people lose weight in a healthy way through balancing the basic health aspects of life, namely nutrition, physical activity and mental health.

These programs contribute to modifying unhealthy behaviors in a thoughtful manner according to each person and his need to be able to change his lifestyle over time. It is wrong for a patient to follow a random diet because it is a delicate issue that needs a specialized doctor to assess the condition by conducting a clinical examination, body mass calculations, measuring the waist circumference, taking the medical history, knowing other treatments that the patient is taking, and requesting laboratory tests for him. Accordingly, the doctor chooses the appropriate and effective treatment for the patient's condition.

Perhaps the presence of such programs is due to the various reasons that can lead to obesity. Nutrition is not the only factor, but genes can be a key factor, which has been proven by

SEPT.OCT 2021

82

WEIGHT MANAGEMENT PROGRAMS AIM TO HELP COMMUNITY MEMBERS ADOPT A HEALTHY LIFESTYLE THAT ENABLES THEM TO FIGHT EXCESS WEIGHT

studies that found that about two thirds of obesity cases are due to genetic factors in addition to environmental changes that increase inactivity and lack of physical activity while increasing the demand for unhealthy foods. There is a wide range of treatment options such as healthy eating, physical activity, behavioral therapy, anti-obesity medications, and weight-loss surgeries. Weight management needs a personalized plan to develop the appropriate treatment according to each person's condition.

Treatments and Programs After determining the cause, the doctor moves to treatment, which requires the development of a comprehensive weight management plan. Now the patient has to know that it takes time to lose weight and it cannot be done in a short period of time. The patient needs to change his wrong behavior and replace it with healthy habits to lose weight and keep it off.

After losing the excess weight, the specialist doctor develops a diet program in which the patient does not feel deprived from food, which encourages him to follow this lifestyle on the long term.

ARTICLE FEATURES . Obesity Medicine

83

ARTICLE FEATURES . Obesity Medicine

Therapy may include following a special diet while taking some medications to treat the defect that led to this weight gain, or the doctor may resort to surgery and that the type of operation is determined according to the patient’s weight and general health condition.

The medical procedure must be appropriate to the patient’s condition in order to ensure optimal results and reach the ideal weight. The more accurate the procedures, the greater the body’s ability to get rid of excess weight.

Among the treatment programs adopted: Increasing physical activity: What is meant here is not sports races or making a lot of effort, but it is enough to add a little movement, such as parking the car far away, or taking the stairs instead of the elevator, or walking in the market for some time. With time, the body will get used to moving, and the obese patient will enjoy walking, so his physical activity will increase little by little. The goal is to exercise about 150 minutes per week. This will become a daily routine.

Behavioral therapy: Among the modern treatments of obesity and overweight are those

SEPT.OCT 2021

84

related to the psychological aspect, after it has been proven that there is a close relationship between the body and the mind. The behavioral therapist deals with the psychological aspects of weight management, with the aim of identifying the thought and behavior patterns that motivate the patient not to eat without feeling hungry, which is the problem that some suffer from where they eat food or sweets when feeling sad or vice versa; this is called emotional eating. Behavioral therapy helps develop skills and enhance mental capacity with the aim of changing lifestyle and aiding weight loss with long-term health benefits.

Low-calorie diet: Follow a special diet that breaks down localized fat, in addition to following some special exercises under the supervision of a special trainer who determines the appropriate exercises to lose body fat. Meals should be rich in protein and low in fats and carbohydrates, and they are part of the treatment plan under the supervision of a specialist doctor to include replacing one or more meals per day that includes foods that provide a specific number of calories, for example, between 800 and 1200 calories per day.

“OBESITY MEDICINE” AIMS TO HELP OVERWEIGHT PEOPLE LOSE WEIGHT IN A HEALTHY WAY THROUGH BALANCING THE BASIC HEALTH ASPECTS OF LIFE, NAMELY NUTRITION, PHYSICAL ACTIVITY AND MENTAL HEALTH.

ARTICLE FEATURES . Obesity Medicine

Anti-obesity drugs: Only the doctor decides whether the medical condition requires taking anti-obesity drugs or not, which are diverse and work in different ways that help regulate appetite and reduce food portions. Anti-obesity medications can also help prevent weight regain, and other medications help you lose weight by changing the way your body absorbs food. This can be done, for example, by reducing the amount of fat your body absorbs.

Weight-loss surgery: After the failure of all types of obesity treatments, and after determining the BMI, the final solution for treating obesity may be surgery, especially for cases that suffer from chronic diseases or have a risk of developing a chronic disease in the future due to excess weight. Surgical procedures reduce appetite and the amount of food a person can comfortably eat in one sitting. It has been shown to cause metabolic and hormonal changes, which play a key role in weight regulation. The hormonal changes that occur prevent weight regain.

Laboratory tests to determine the causes of obesity Weight management requires diagnosing the cause of obesity by conducting a series of lab tests to determine the cause in order to develop the appropriate treatment plan. The beginning of excess weight management to get rid of obesity requires determining the cause in the first place, and this is done by conducting a set of laboratory tests to determine the cause then finding the right treatment. Also, each body has its own nutritional needs. After the examinations, the doctor can develop a diet with a comprehensive treatment plan to prevent the risk of developing health problems during dieting, such as not losing weight or fainting and dizziness.

After determining the BMI and the rate of obesity or weight gain that the patient suffers from, the doctor initially resorts to conducting some tests to ensure that there is no health problem that contributes to weight gain, in rare cases as a result of a medical problem that affects the slow metabolism, such as Cushing’s syndrome or thyroid inactivity.

AFTER THE FAILURE OF ALL TYPES OF OBESITY TREATMENTS, AND AFTER DETERMINING THE BMI, THE FINAL SOLUTION FOR TREATING OBESITY MAY BE SURGERY, ESPECIALLY FOR CASES THAT SUFFER FROM CHRONIC DISEASES OR HAVE A RISK OF DEVELOPING A CHRONIC DISEASE IN THE FUTURE DUE TO EXCESS WEIGHT.

85

ARTICLE FEATURES . Obesity Medicine

The lab tests required to determine the cause of obesity: Thyroid hormone (TSH), which is secreted by the pituitary gland to stimulate the thyroid gland and induce it to secrete its functional hormones. Hypothyroidism means excess TSH secretion and obesity is one of its symptoms.

Vitamin D analysis, since its deficiency in the body affects weight loss due to its hormonal functions that have an effect on the thyroid gland functions, which controls metabolic rates. Therefore, vitamin D must be measured in the body before following a diet in order for the doctor to prescribe vitamins necessary to increase low levels of vitamin D.

Cholesterol analysis to know the levels of fats in the blood, namely the triglycerides that accumulate as a result of converting calories into fats and are stored in fat cells, and these fats also increase the risk of diabetes.

Blood sugar test: Studies have shown that obese people are more likely to develop type 2 diabetes because the body is unable to manage carbohydrates, which leads to high blood glucose and increased insulin resistance.

Complete blood count: A low level of hemoglobin in the body indicates a lack of iron, which stimulates the production of hemoglobin and thus increases the level of energy needed at the gym, while iron deficiency affects thyroid hormones.

Liver function tests: Obesity causes the accumulation of fat above the liver, causing fatty liver disease, and this in turn affects the liver function tests. Obesity can also cause health problems in the gallbladder, which increases the bile in the blood, as bile tests are part of the liver function tests.

FSH is the ovarian stimulating hormone.

Ovarian laziness means an increase of this hormone in the body. The ovary secretes estrogen, which is necessary to regulate the storage of body fats.

SEPT.OCT 2021

86

LH is one of the female sex hormones; high LH hormone occurs in the case of PCOS, which causes overweight and obesity.

Estrogen, known as the female hormone secreted by the ovaries, but after menopause, this hormone decreases significantly, which leads to obesity, especially in the abdomen and buttocks area, where fat accumulates. Estrogen regulates fat storage in some areas of the body, so it is one of the hormones that cause obesity.

Testosterone, known as the male sex hormone, is present in high levels in men and in low levels in women. One of the testosterone hormone functions is to strengthen the muscles, help burn fat and strengthen the bones. The deficiency of this hormone in the body of a woman or a man leads to the accumulation of fat in the body and thus is one of the causes of obesity.

Cortisol is a hormone secreted by the adrenal gland and has multiple functions, including regulating metabolism related to energy storage and consumption in addition to regulating the distribution of fat in the body.

Leptin hormone is responsible for regulating the sensation of hunger and satiety, as its deficiency leads to an increase in appetite and thus may be a cause of obesity.

THE PATIENT NEEDS TO CHANGE HIS WRONG BEHAVIOR AND REPLACE IT WITH HEALTHY HABITS TO LOSE WEIGHT AND KEEP IT OFF. AFTER LOSING THE EXCESS WEIGHT, THE SPECIALIST DOCTOR DEVELOPS A DIET PROGRAM IN WHICH THE PATIENT DOES NOT FEEL DEPRIVED FROM FOOD, WHICH ENCOURAGES HIM TO FOLLOW THIS LIFESTYLE ON THE LONG TERM.

Shaping the industry, keeping the patient first.

A unified voice for the region’s MedTech industry.

Add your voice by joining the Mecomed Medical Technology Association Middle East & Africa

For enquiries please contact: +971 4 513 6977 | info@mecomed.com

www.mecomed.com

ARTICLES

Al-Ahli Hospital performs complex gynaecological surgery

By Dr. Mumtaz Rashid, Consultant OB/Gyn at Al-Ahli Hospital / Qatar

A

l-Ahli Hospital performed a successful vaginal hysterectomy along with the suspension of vaginal vault (upper end of vagina) procedure for a 52-year-old woman who had been suffering from prolapse of uterus and vagina for the last 5 years.

Dr. Mumtaz Rashid Consultant Ob&Gyne at Al-Ahli Hospital said that this kind of procedure requires the skills and expertise of a vaginal surgeon. Removing the uterus (vaginal hysterectomy) wouldn’t have been sufficient in this case to cure the prolapse, this additional step was to prevent the vault coming down after hysterectomy. The basic problem is weakness of the ligamentous support holding the uterus and vagina. In addition, she said: “Vaginal prolapse is the herniation of the pelvic organs to or beyond the vaginal walls. It is reported to be the most common reason for hysterectomy in women over age 50.”

“When she attended my clinic, she was rather frustrated with the worsening symptoms of genital prolapse, which included her uterus

SEPT.OCT 2021

88

and vagina hanging out of her body most of the times. On examination there was 3-4th degree of utero-vaginal prolapse with uterus coming out of the vagina for up to 3cm.”

Dr. Mumtaz Rashid added: “We performed vaginal hysterectomy, repair of the vaginal wall prolapse and vault suspension procedure. The last procedure is technically demanding and only handful of surgeon are trained to do it.

She recovered well after the surgery and went home on 3rd day. She was checked 2 months later when her vagina is well supported.” Dr. Mumtaz Rashid further said that vaginal hysterectomy is an invasive option, provides many benefits to patients, including quicker recovery time, less pain and no visible scarring so they can return to their busy lives more quickly.

VAGINAL PROLAPSE IS THE HERNIATION OF THE PELVIC ORGANS TO OR BEYOND THE VAGINAL WALLS.

ARTICLES

Al-Ahli Hospital performs successful lumbar fusion surgery

By Dr. El Fatih Bashir El-Malik, Neurosurgeon at Al-Ahli Hospital / Qatar

D

r. El Fatih Bashir El-Malik explained that sometimes the delicate balance between stability and elasticity of the spinal column may be lost leading to what is known as spine instability symptoms, which are usually acute or chronic low back pain with or without sciatica.

Al-Ahli Hospital has performed a successful surgery for a 50-year-old lady presented to neurosurgery clinic with recurrent low back pain and right sciatica for four months. That was associated with progressive weakness of the right foot or as the medical term ‘Foot Drop’.

It is to be noted that she had undergone lumbar disc removal surgery twice in UK. After clinical examination and radiological investigations, the hospital decided that a third surgical intervention is indicated to remove the pressure from the affected nerve and to restore the lost function of the foot.

However, this time surgery should be in the form of lumbar fusion/decompression. It was supposed to decrease the risk of recurrence and ensure the stability of the lumbar region.

The surgery was done successfully and the function of the right foot was restored completely.

Dr. El Fatih Bashir El-Malik, the consultant of neurosurgery said, The anatomical structure of the spinal column is composed of large number of discs and other symmetrical joints that overlap on top of each other to allow for the motion in all directions. At the same time, ligaments which surround the joints will maintain a certain degree of stability in all positions.

He explain that sometimes, this delicate balance between stability and elasticity of the spinal column may be lost leading to what is known as spine instability symptoms, which are usually acute or chronic low back pain with or without sciatica.

The suspected cases undergo physical examination and special investigations for further evaluation, including dynamic X-rays, which study the relationship between the spine elements in different positions that affect daily activities.

In the intractable cases that do not respond to conservative treatment like medications and physiotherapy, surgical intervention is advised this includes fixation of the affected levels using special implants that is inserted in the spine with no contact with the nervous system. Those implants contain special type of bone graft fuses the region further on the long term for additional stability. These operations are considered to be complex as they include reconstruction of the treated levels of the spine.

However, patients are usually able to walk the next day after surgery and hospital stay is few days only. This is one of the routinely done operations in the Department of Neurosurgery with great results.

Before

THE ANATOMICAL STRUCTURE OF THE SPINAL COLUMN IS COMPOSED OF LARGE NUMBER OF DISCS AND OTHER SYMMETRICAL JOINTS THAT OVERLAP ON TOP OF EACH OTHER TO ALLOW FOR THE MOTION IN ALL DIRECTIONS.

After

89

ARTICLES

Hypertension… Did you get a high blood pressure reading? What to do next?

By Dr. Malak El Ess, Specialist Internal Medicine at Al-Ahli Hospital / Qatar

H

ypertension is defined as a systolic blood pressure of 140 mm Hg or more, or diastolic blood pressure (DBP) of 90 mm Hg or more.

What is the latest classification of hypertension?

ACC/AHA classification 2017 1. Elevated blood pressure with systolic pressure between 120 and 129 mm Hg and diastolic pressure less than 80 mm Hg 2. Stage 1 hypertension, with a systolic pressure of 130 to 139 mm Hg or a diastolic pressure of 80 to 89 mm Hg 3. Stage 2: Systolic 140 mm Hg or greater, diastolic 90 mm Hg or greater

Is one reading of high blood pressure enough to diagnose hypertension?

No, to diagnose hypertension, we need an average of 2 readings on 2 different occasions.

What is white coat hypertension?

It is when patients have elevated BP readings in the clinic with normal BP readings at home. Patients with such presentations may have an increased risk for cardiovascular disease “White coat hypertension can be further investigated with ambulatory BP monitoring (monitor attacked to the patient for 24 hrs) ‘’

What causes hypertension?

Hypertension can be either primary or hypertension which accounts for more than 90% of the cases or secondary hypertension which is much less common and usually is due to renal, vascular, endocrine disorders, or sleep apnea.

How does hypertension present?

Commonly high BP is silent and goes on for

SEPT.OCT 2021

90

years without symptoms, some patients will present in advanced stages with headaches, nose bleeds, and breathlessness.

What are the complications of high blood pressure?

• • • • • •

Stroke Angina, Myocardial infarction, Heart failure Peripheral artery disease Chronic kidney disease.

Vision loss Sexual dysfunction

How to measure your blood pressure?

• • • •

•

Sit relaxed for five minutes Avoid caffeine, exercise, smoking and empty bladder before checking.

Use a proper BP device and put the cuff at the heart level Record BP in both arms and choose higher reading, repeat in 2 minutes if needed Keep a record of your blood pressure readings for comparison

• What tests are needed in Hypertension evaluation?

• • • •

CBC, Urinalysis Fasting blood glucose or A1c Serum sodium, potassium, creatinine, and calcium TSH, lipid profile

In addition to an ECG and possibly echocar-

HYPERTENSION CAN BE EITHER PRIMARY OR HYPERTENSION WHICH ACCOUNTS FOR MORE THAN 90% OF THE CASES OR SECONDARY HYPERTENSION WHICH IS MUCH LESS COMMON AND USUALLY IS DUE TO RENAL, VASCULAR, ENDOCRINE DISORDERS, OR SLEEP APNEA.

ARTICLES

diography. If secondary HTN is suspected then more tests are needed:

•

What is the treatment of hypertension?

•

•

•

• •

Lifestyle modifications: Best results if 2 or more of those modifications were done Weight loss, using DASH diet rich in fruits and vegetables; can reduce systolic BP by 5-20 mmHg for each 10 kgs dropped Limit smoking and alcohol intake Reduce sodium intake to less than 1.5 grams of sodium daily; can reduce systolic BP by 5-6 mmHg

Aerobic exercise at least 30 minutes daily for five days; can reduce systolic BP by 5-8 mmHg Maintain adequate intake of dietary potassium, calcium and magnesium

Medications If lifestyle modifications fail to control blood pressure, then the patient should be started on medications that are chosen according to his age, race, other medical comorbidities and the stage of hypertension. This should be discussed individually with physicians there are multiple classes of antihypertensive with a different modes of action and indications.

91

EXHIBITIONS

MEDICA 2021 + COMPAMED 2021: For the restart as an in-person event, participations reflect the optimism of the medical technology industry man Trade Fair Industry) are supporting. These bodies have recently jointly set up an assistance programme to support innovative small and medium-sized companies (headquartered in Germany) in participating in trade fairs. This assistance comprises a grant of up to 12,500 Euro to cover costs for stand rental and stand construction. Objective: To reinforce export marketing in order to gain new customers and tap into new markets. Apply now or lose your chance! To receive a grant to participate in MEDICA 2021 or COMPAMED 2021, the grant application must be submitted to the German Federal Office for Economic Affairs and Export Control (find more information at: https://www. bafa.de; to contact the MEDICA and COMPAMED team: exhibitor@medica.de) by the relevant exhibitor (following registration) by 15 September.

T

he medical technology industry and its suppliers are looking forward to heading to the world’s leading industry platforms, MEDICA 2021 and COMPAMED 2021, with optimism. The booking figures for both events confirm this.

Almost all of the halls (excepting halls 13 and 14) at the Düsseldorf Trade Fair Centre will be occupied from 15 to 18 November, when the trade fairs will be held on-site once more.

“Despite the planning time frame for companies becoming far shorter due to the pandemic, a total of over 2,500 exhibitors from 68 nations was attained three months before the trade fair started. In particular, bookings from co-exhibitors on the big joint stands are still being snapped up like hotcakes”, reports Christian Grosser, the Director for Health & Medical T echnology at Messe Düsseldorf. He believes that this is proof of MEDICA and COMPAMED’s internationally prestigious position, despite the tough conditions in which they are taking place.

Due to their high level of global attraction, both events are also on the list of the selected trade fairs that the German Federal Ministry for Economic Affairs and Energy (BMWi) in conjunction with AUMA (The Association of the Ger-

SEPT.OCT 2021

92

THE EXHIBITOR DATABASE, INTERACTIVE HALL PLAN AND THE TICKET SHOP ARE ALREADY UP AND RUNNING.

Innovations, trends and topics dedicated to the pandemic The corona pandemic has pushed the healthcare sector firmly into the spotlight and has shown up weak points in our care system.

Hospitals, outpatient service providers and care institutions have an increased need for medical and laboratory technology, a wide variety of medical products and personal protective equipment, and in particular new digital healthcare solutions or point-of-care telemedical applications, due to the pandemic. The exhibitors will present many innovations focused on these themes, and the specialist forums and accompanying conferences on these will amplify the expert dialogue and transfer of knowledge, the content of both of which will be perfectly tailored to the needs of the important target groups in the healthcare industry.

Once again, CompuGroup Medical (CGM) will be one of the biggest exhibitors at MEDICA. They are an international provider of medical software solutions that is addressing trending topics. Michael Franz, Head of Brand Communication at CGM SE & Co. KGaA, is excited about

EXHIBITIONS

the upcoming trade fair: “CGM is delighted to be able to take part in MEDICA once again, at long last. From our point of view, this new hybrid concept helps to fulfil our high expectations for trade fairs, even during a pandemic. Trade fairs should stimulate interactive exchange between all participants, across all sectors. We will be able to demonstrate this to our customers and interested parties with aplomb at the biggest healthcare trade fair in the world. All of the current digital themes are shown using hands-on use cases, covering the patient’s entire journey.”

The theme segments of MEDICA are oriented towards the complete needs of outpatient and inpatient care. An overview of their allocation to the trade fair halls is available online (link: https://www.medica.de/sitemap2021).

The MEDICA segments are: Lab technology & diagnostics, electrotherapy and medical technology, disposables and consumables, information and communication technology (digital health) and physiotherapy and orthopaedic technology.

Fittingly, the exhibitors at COMPAMED (approx.

400 exhibitors) will showcase the entire range of products and services that the supplier market provides for medical technology: from individual components and parts to high-tech solutions, innovative materials and packaging to complete contract manufacturing.

The digital services launch was a success!

The profiles of all exhibitors admitted to date can be looked up online on the “Companies & Products” database, and can be filtered using a variety of criteria, on the industry portals MEDICA.de and COMPAMED.de. The interactive hall plans provide information on the exact stand locations of the exhibitors in the individual halls (link: https://www.medica.de/de/interaktiver_hallenplan). The ticket shop has also been launched. In line with the hybrid event concept of MEDICA and COMPAMED, tickets can now be purchased either as a hybrid ticket for a one-day visit on site and parallel use of the extensive digital services (45 euros) or as a pure digital ticket (without a visit on site/ 30 euros).

All of the specialist forums which are integrated into the themed segments of the trade fair, such as the MEDICA CONNECTED HEALTHCARE FORUM (including the MEDICA Start-up COMPETITION and the Healthcare Innovation World Cup), the MEDICA HEALTH IT FORUM and the MEDICA LABMED FORUM, are some of the programme items that are offered both on-site and online, which can be accessed with the appropriate ticket. The COMPAMED HIGH-TECH FORUM by IVAM (the International Microtechnology Business Network) and the COMPAMED SUPPLIERS’ FORUM by DeviceMed are special COMPAMED highlights.

In addition to these highlights, there will also be a programme of on-stage events at the epicentre of the trade fair. In parallel, speeches, discussions and even the award ceremonies can be viewed via live stream on the industry portals MEDICA.de and COMPAMED.de with the right ticket (link to overview of all forums and their themes for 2021: https://www.medicatradefair.com/forums).

Further highlights of MEDICA 2021’s programme include the 44th German Hospital Conference (as a live stream) and the English language conferences DiMiMED and MEDICA MEDICINE + SPORTS CONFERENCE. They bring together the best of the best from the fields of international military and disaster medicine, and sports medicine and sports science, in Düsseldorf and can be followed with one of two tickets: either live in-person, or as a live stream.

The trade fair halls are open from 10 a.m. to 6 p.m. on all days of the trade fair. All visitors and exhibitors must comply with the the 3G rule (they must be vaccinated, recovered or tested: this is what the three Gs stand for in German) in order to enter the trade fair premises. Tickets can be purchased exclusively online.

All information, including current news on the hygiene and infection protection concept at MEDICA 2021 and COMPAMED 2021, can be viewed online at: https://www.medica-tradefair. com / https://www.compamed- tradefair.com.

THE EXHIBITORS WILL PRESENT MANY INNOVATIONS FOCUSED ON THESE THEMES, AND THE SPECIALIST FORUMS AND ACCOMPANYING CONFERENCES ON THESE WILL AMPLIFY THE EXPERT DIALOGUE AND TRANSFER OF KNOWLEDGE, THE CONTENT OF BOTH OF WHICH WILL BE PERFECTLY TAILORED TO THE NEEDS OF THE IMPORTANT TARGET GROUPS IN THE HEALTHCARE INDUSTRY.

93

EXHIBITIONS

Over 200 leading healthcare thinkers and experts lined up for the 44th World Hospital Congress

A

n ensemble of over 200 presenters comprising of healthcare experts, leading industry thinkers, and best practice presenters is being lined up for the 44th World Hospital Congress – the flagship event of the International Hospital Federation (IHF) – which will take place on 8 to 11 November in Barcelona, Spain, along with an online broadcast exclusively available for virtual attendees.

Hosted by La Unió Catalana d’Hospitals (Catalan Hospital, Health and Social Services Association - UCH), the Congress is poised to be one of the first hybrid healthcare management events that will happen in the region. It is a unique global forum where industry executives from more than 50 countries will convene to share new knowledge, expertise and good practices in hospital and healthcare leadership, management, and service delivery.

Over 60 sessions have been arranged to fill a well-thought, wide-ranging program that covers important topics related to the theme: People on board: Transforming healthcare by blending agility, responsiveness, and resilience. Among several sessions across the four-day event, the following are some of the thought-provoking topics available in the program:

Getting ready for the next global pandemic: European and North American perspectives Public health leaders and hospital CEOs will share their views on how the next global pandemic might unfold and how they are leading their organizations to prepare for the next global health crisis. Hear from: • Dr. Rod Hochman, President and CEO, Providence, United States • Prof. Natasha Azzopardi, Director, World Health Organization • Dr. Bechara Couchair, Vaccinations Coordinator - White House COVID Response Team

SEPT.OCT 2021

94

•

•

•

Prof. Josep M Campistol, CEO - Clinic Hospital, Hospital Clínic Barcelona, Spain Wright Lassiter III, President and CEO, Henry Ford Health System, United States Bertrand Levrat, CEO, Geneva University Hospital (HUG), Switzerland

Accelerating research, development and distribution of the COVID-19 vaccine: Lessons learned from key stakeholders Various stakeholders will discuss key learnings from the fast-tracked journey of the COVID-19 vaccine and how these can be applied to the near future. Hear from: • Dr. Hans Kluge, Regional Director for Europe, World Health Organization • Dr. Carmen Cabezas, Secretary of Public Health, Department of Health of the Generalitat de Catalunya, Spain • Thomas B. Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations • Dr. César Hernández, Head of Department of Medicines for Human Use, Spanish Agency for Medicines and Medical Devices, Spain • Dr. John N. Nkengasong, Director, Africa Centres for Disease Control and Prevention, Ethiopia

Nursing leadership in transforming healthcare during a worldwide pandemic: Examples from the field The importance of global nursing leadership initiatives such as Nursing Now and the Nightingale Challenge will be tackled. Nurse leaders in various roles will share the challenges they faced, successes and innovations during the pandemic. Hear from: • Dr. Robyn Begley, CEO, American Organization for Nursing Leadership; Senior

OVER 60 SESSIONS HAVE BEEN ARRANGED TO FILL A WELL-THOUGHT, WIDE-RANGING PROGRAM THAT COVERS IMPORTANT TOPICS RELATED TO THE THEME: PEOPLE ON BOARD: TRANSFORMING HEALTHCARE BY BLENDING AGILITY, RESPONSIVENESS, AND RESILIENCE.

EXHIBITIONS

•

•

•

•

•

VP and Chief Nursing Officer, American Hospital Association, United States Lord Nigel Crisp, Former CEO at NHS in England and Former Permanent Secretary of the United Kingdom Department of Health Dr. Maria Eulàlia Juvé Udina, Board Member, International Council of Nurses; Nurse Executive, Catalan Institute of Health, Spain Prof. Adelaida Zabalegui, Vice Director of Nursing, Hospital Clinic of Barcelona, Spain Romnick Aguilar, Acting Chief Nurse and Infection Prevention and Control Officer, San Pedro Jose L Amante Emergency Hospital, Philippines Zipporah Iregi, Nursing Officer Intern, Kitui County Referral Hospital, Kenya

Harnessing innovations to build back better: European lessons from the pandemic Key innovations in the hospital sector will be explored, specifically the areas of telemedicine and technological solutions, skill mix, and bed management to draw lessons on how to build back better our hospital services through adoption, implementation and scaling up of innovations. Hear from: • Dr. Josep Figueras, Director, European Observatory on Health Systems and Policies • Prof. Dr. med. Reinhard Busse, Head of the Department of Health Care Management, Berlin University of Technology, Germany • Dr Nick Fahy, Senior Researcher, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK • Prof. Marc Noppen, CEO, UZ Brussel, Belgium • Dr. Dimitra Panteli, Programme Manager, Lead Health System Innovation, European Observatory on Health Systems and Policies

•

r. Liisa Maria Voipio Pulkki, Director D General of Strategic Affairs and Chief Medical Officer, Finnish Ministry of Social Affairs and Health, Finland

Humanizing technology for smart healthcare delivery: The COVID-19 impact This will demonstrate how technology-enabled healthcare has huge potential to better humanize healthcare and deliver a more personable and dedicated patient experience. It will focus on how healthcare systems and services have fundamentally changed throughout the pandemic and how digitally enabled healthcare is now a mainstay of many hospital services around the world. Hear from: • Richard Stubbs, Chief Executive, Yorkshire & Humber AHSN, United Kingdom • Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., India • Dr. Anne Snowdon, Chief Scientific Research Officer, HIMSS • Dr. Heidi Sveistrup, CEO & Chief Scientific Officer, Bruyére Research Institute, Canada • Yulun Wang, Founder and Chairman, World Telehealth Initiative, United States

WITH A HIGHLY COMPREHENSIVE PROGRAM TO OFFER, THE IHF AND UCH INVITE HEALTHCARE PROFESSIONALS TO PARTICIPATE AND BECOME PART OF THE IMPORTANT DISCUSSION ON THE TRANSFORMATIONS THAT ARE AFFECTING CONTINUOUS EVOLUTION IN THE GLOBAL HEALTH SYSTEM.

In addition to the plenary and parallel sessions, there will be posters on display, tradeshow and exhibition by participating organizations and providers, hospital visits, special events for those attending in person and numerous networking opportunities both for presential and virtual attendees. With a highly comprehensive program to offer, the IHF and UCH invite healthcare professionals to participate and become part of the important discussion on the transformations that are affecting continuous evolution in the global health system.

For more information visit www.worldhospitalcongress.org or contact congress@ihf-fih.org

95

ARTICLES

Immunotherapy

By Dr. Mohanad Diab, Consultant Medical Oncologist, Head of NMC Group Oncology

O

ver the last two years, the advances made by immunotherapy in attacking cancers previously thought unstoppable have been especially promising.

In fact, the results indicate that this form of treatment is revolutionary and could eventually lead us to find a cure for cancer.

“For many advanced cancers, we were previously unable to do anything for the patient and were simply forced to send them home.

But immunotherapy has opened the door to better palliative care, and has even helped stop the progress of cancers in quite many patients,” Immunotherapy uses a class of medicines that stimulate the patient’s immune response, and teach white blood cells to search and attack and act against cancer cells. Unlike traditional chemotherapy, these medicines do not kill healthy cells. More and more resources are currently being invested into researching immunotherapy.

“I personally have a patient in her 40s with a nasopharynx cancer who has been receiving one of the immunotherapy drugs. In the past, I would have said there was nothing more I

SEPT.OCT 2021

96

could do for her and she would have had just about six months to live. But this patient is still alive, until now, and the size of her tumor has been shrinking,” and her situation improved clearly.

As in her case, many new immunotherapy drugs have helped these cancer patients a lot and this represents a medical breakthrough.

“Before we had chemotherapy, patients were complaining a lot of its side effects.. Chemotherapy helped us to improve the outcome of these patients and now immunotherapy has added more and more.

In fact, a recent study released recently showed that a combination of chemotherapy and immunotherapy can be especially effective in some cases with minimal side effects. There are also other advances in the field. Initially, immunotherapy could only be used against cancer cells if the protein receptors on their surface responded to the immunotherapy medication, thus enhancing the body’s immune response.

This was determined through molecular genetic testing before the treatment was administered.

“Very recently, however, researchers have found other medicines that do not even need a positive response from protein receptors.

This means that immunotherapy can potentially be used to treat even more cancer patients in the future.

IMMUNOTHERAPY USES A CLASS OF MEDICINES THAT STIMULATE THE PATIENT’S IMMUNE RESPONSE, AND TEACH WHITE BLOOD CELLS TO SEARCH AND ATTACK AND ACT AGAINST CANCER CELLS. UNLIKE TRADITIONAL CHEMOTHERAPY, THESE MEDICINES DO NOT KILL HEALTHY CELLS. MORE AND MORE RESOURCES ARE CURRENTLY BEING INVESTED INTO RESEARCHING IMMUNOTHERAPY.

#Hospotel

97